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Abstract
PETER BENJAMIN STRANGES: Design of protein-protein interactions via β-strand
pairing
(Under the direction of Brian Kuhlman Ph.D.)
The design of new protein-protein interfaces is a test of our understanding of protein
interaction biophysics and can provide new tools to understand cell biology. Methods to
accurately design high-affinity interactions have not been established, making it necessary to
devise new strategies to facilitate the design process. Solvent exposed main chain atoms on
β-strands are prone to interact with other exposed strands and could serve as the basis for the
design of a novel interaction. This dissertation describes the application of β-strand pairing to
design homodimeric and heterodimeric complexes. It also addresses the successes and failures
in computational interface design to determine how design methods need to be improved.
One of the most common ways that proteins interact is the formation of symmetric ho-
modimer. A way to test the hypothesis that β-strand mediated interactions can be accurately
designed is to redesign a monomeric protein to form a symmetric homodimer via β-strand pair-
ing. A computational method in Rosetta was used to find monomeric proteins with exposed
β-strands then redesign them to form a symmetric homodimer by pairing exposed β-strands to
form an intermolecular β-sheet. A crystal structure of one designed complex closely matches
the computational model (RMSD = 1.0 A˚). This work demonstrates that β-strand pairing can
be used to computationally design new interactions with high accuracy
After successful design of a homodimer, β-strand pairing can be extended design to het-
erodimers. A computational protocol is described that identifies proteins with exposed strand
capable of pairing with an exposed strand on a target protein. The interface of the identified
protein is then redesigned to allow it to bind to the target protein. Experimental testing
of proteins designed to bind RalA and PCSK9 show that no interaction is made. Directed
evolution of the scaffold proteins could allow them to bind to their target.
iii
Most computational protein interface designs from our laboratory and others fail to form
when tested experimentally. Successful and failed protein interface designs were examined to
see if they provided answers about what works in interface design. Successful designs were, in
general, more hydrophobic than failed designs and had few designed hydrogen bonds buried
at the interface. Rosetta designed hydrogen bonds were found not to match hydrogen bond
distributions observed in high resolution crystal structures. The hydrogen bonding portion
of the energy function needs to be improved to allow for design of polar interfaces similar to
those found in native proteins.
iv
To the Flying Spaghetti Monster.
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Chapter 1
Introduction
The energetics that govern how a protein folds from an extended chain into a final con-
formation are understood in principle (1), but reliable techniques to accurately predict final
structure based on sequence information alone have proved elusive (2). Additionally, a clear
picture of how, once folded, a protein interacts with other proteins has not been elucidated.
A complete understanding of how these processes work cannot be determined until the forces
stabilizing the folded and interacting states are explained. De novo protein and protein-protein
interaction design provides one way of comprehending these forces. The de novo design of a
protein means rationally choosing a sequence that will fold into a target final structure (3).
Failed and successful designs can provide valuable information about the forces involved in
stabilizing a three-dimensional structure. De novo protein interface design extends this idea
to design a sequence capable of forming an interaction between two or more protein chains.
A designed interface that forms experimentally can provide valuable information about the
physical chemistry of protein-protein association (4).
1.1 Protein-protein interaction design
Protein-protein interaction networks monitor the internal and external state of a cell and
act as signaling circuits to transmit information and change the phenotype of the cell. Genome
sequencing and proteomic databases provide a nearly complete list of the available modules for
cell regulation, what is lacking is an understanding of how these parts fit together (5). Recent
high throughput techniques have allowed some of these interaction networks to be mapped
(6), but a complete understanding of cell signaling remains out of reach. Like protein design,
the design of new signaling circuits provides a test of our understanding of a basic biological
process. An understanding of which interactions work, which do not, and why they do not can
provide valuable information about natural protein-protein interactions (5). Novel methods
to alter natural cellular interactions provide a wealth of information about the regulation and
response of the signaling circuit (7).
The design of new protein-protein interactions has provided valuable tools to undersand the
way nature constructs interactions and modify cell signaling systems. Many natural proteins
exist as large complexes of small subunits that form symmetric interfaces in order to construct
the larger, functional, protein (8). Grueninger et al. used a simple mutagenesis approach to
construct ordered, symmetric oligomers out of monomeric proteins (9). This demonstrates a
mechanism that nature may use to build multimeric proteins. Protein interactions that can
be turned on and off with light have be used to control cell motility (10; 11) and membrane
recruitment of certain proteins (12). These tools provide the ability to selectively alter pro-
tein function in different areas of the cell. Modular domain recombination of protein-protein
interaction domains can create new cellular responses by providing alternative protein interac-
tion networks (reviewed in (13) and (14)). This method recombines protein domains to form
non-native interactions with a scaffold that serves to orient and control the flow of informa-
tion. This method has been used to tune and improve metabolic flux (15), activate guanine
exchange factors with a non-native input (16) and engineer feedback loops into MAP kinase
signaling (17). These studies demonstrate that engineered protein-protein interactions can
control output and tease apart natural protein pathways.
One of the most common ways to obtain a new protein-protein interaction is though
directed evolution (18). Phage display (19), yeast display (20) and ribosomal display (21)
have provided a wide variety of affinity reagents and protein functions used in cell biology. For
example the fusion of a PDZ domain to an FNIII domain followed by directed evolution of
the FNIII domain allowed the construct to recognize alternate PDZ binding peptides (22). A
multiple laboratory effort engineered high affinity binders to 20 SH2 domains using a variety of
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directed evolution techniques (23). It now appears that it is possible to use directed evolution
to obtain an affinity reagent to any target that can be purified. A remaining challenge is
obtaining binders that recognize a conformational state, post translational modification, or
are specific for only one member of a protein family.
Biological engineering has made it evident that more tools are needed to control cellu-
lar machinery. Some of the primary needs are orthogonal protein interaction pathways with
variable affinity, specificity (5), and computer aided design strategies to design new logic
circuits(24). Metabolic pathway design requires protein interactions that can be predictably
regulated and have tunable affinity for certain upstream and downstream effectors (25). Com-
putational methods of modifying and designing new protein interactions can provide the tools
to meet the needs of biological engineering (26) .
1.2 Computational protein interface design
Computational protein design attempts to search the sequence and conformation of a
polypeptide chain to minimize the energy of the structure. All computational design protocols
have two components, a search function to explore sequence and conformational space and
an energy function that evaluates the fitness of a particular search model (27). Successful
computational design of to monomeric proteins quickly suggested that these same models
could be applied to engineer protein-protein interactions (28).
The idea that the molecular structure of proteins is responsible for their interaction has
been recognized since the time that the first few crystal structures of protein complexes were
determined (29; 30). However, the ability to accurately model how two proteins will form
a complex has proved elusive (31). De novo computational interface design is a test of our
understanding of the forces governing protein-protein interactions. A typical computational
design run involves modeling the rigid body orientation of two or more protein chains in a
conformation that will allow them to interact. Next, the computational protocol designs amino
acids near the modeled interaction to stabilize the complex state. The design goal determines
which residues near the interface are allowed to change. A common aim is to redesign residues
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on a natural protein to enable it to bind to another natural protein. In this case the natural
protein that is left unchanged is called the target protein and the redesigned protein is called
the scaffold.
Computational interface design has helped create new interactions and functions that na-
ture has not sampled. Recent progress in computational interaction design is reviewed in
(26) and (32). Computational design provides several advantages over directed evolution and
modular domain recombination. Most importantly, computational design can be used to tar-
get a specific interaction site for design and constrain the design to satisfy a particular goal.
For example Reina et al. used a computational protocol to predictably engineer a Class I
PDZ domain to recognize Class I and Class II target peptides (33). Similarly, Shifman and
colleagues were able to design mutations to alter specificity of calmodulin for different target
peptides (34; 35). Another group was able to find an array of substrates for a protein chap-
erone by investigating the sequences allowed to bind to a target cite on the chaperone (36).
An antibody’s affinity for its target can be improved beyond in vivo affinity maturation by
computationally optimizing interface electrostatics (37). Computational design also allows for
favoring one type of interaction (positive design) while simultaneously disfavoring an alternate
interaction (negative design). This idea has been used to design heterodimers that do not
interact with off target proteins (38; 39; 40).
Computational protein-protein interaction design has the potential to create proteins ca-
pable of predictably changing cell signaling. One exciting advance is the development of a
computational framework to design a multi-function protein hubs capable of interacting with
a variety of partners (41). To achieve this goal computational design will need to be able to
repeatably engineer novel protein-protein interactions. The majority of successful computa-
tional designs addressed in the reviews above involve the redesign of an existing interaction for
increased affinity or altered specificity. Most success computational novel interaction design in-
volves idealized systems such as α-helical pairing (42; 38; 40) or hot spot grafting (43; 44). New
approaches to interface design are needed to create a toolkit capable to predictably modifying
cellular function.
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1.2.1 Interface design using Rosetta
The Rosetta suite of macromolecular modeling software (45) was used for all protein design
steps in this work. The energy function is comprised of terms for all aspects thought to be
important to protein structure (46).
Eprotein =Wlj atrElj atr +Wlj repElj rep +WHbondEHbond +WsolvationEsolvation +WaaEaa+
WpairEpair +WramaErama +WrotamerErotamer −WreferenceEreference
These terms include physically based potentials to capture van der Waals interactions
(Wlj atrElj atr and Wlj repElj rep) and solvation energy (WsolvationEsolvation). The other, knowl-
edge based terms, are parameterized based on high resolution structures in the Protein Data
Bank (PDB). Hydrogen bond energy (WHbondEHbond) is calculated based on the distance and
angles between the acceptor and donor atoms (47). The other terms account for electro-
static pairing (WpairEpair), torsional preferences (WramaErama and WrotamerErotamer) and the
contextual preferences of amino acids ( WaaEaa and WreferenceEreference). Rosetta’s search
function is Metropolis Monte Carlo (48) with simulated annealing (49), which allows the se-
quence and conformation of a protein to be quickly sampled during a design simulation but
does not guarantee finding a global minimum.
Rosetta is well suited to design new protein-protein interactions (50). Rosetta has the
ability to perform rigid body protein docking (51), backbone conformation sampling (52), and
sequence design (53). The recent development of an XML scripting language allows many
design and sampling modules to be easily incorporated into a single simulation. (54). Rosetta
can increase the affinity of a protein interaction (55), alter the specificity of existing interactions
(56; 57; 58; 59) and stabilize an interaction to serve as a biosensor (60). More recently, Rosetta
has proven to be capable of designing novel protein interactions (61; 62; 63). These successes
are addressed in Chapter 4. The next step is to move beyond from proof of concept designs to
create novel tools, orthogonal pathways, and enzymatic function for biological engineering (26).
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1.3 Complications in computational protein interface design
The design of a protein-protein interactions from scratch has proven to be a very difficult
problem (reviewed in (26; 32)). Few designed interfaces have been experimentally verified
to form a complex that matches the computational model. Computational interface design
combines two challenging modeling goals, rigid body orientation between protein chains and
the design of sequence that will allow those chains to interact (28). Most computational designs
of a de novo interface have no measurable affinity (64). The ones that do interact often have
low affinity (KD > 100 µM) (4; 65) or do not form the expected complex (66). Directed
evolution can help overcome low affinities by sampling additional sequences that were not in
the designed model (61). Computational redesign of existing protein-protein interactions for
enhanced affinity has also been plagued by similar problems. Many of the mutations predicted
to increase affinity actually weaken the interaction or the redesigned proteins (67; 68).
A protein interface presents several modeling challenges that are not relevant for design
of a monomeric protein. Transient protein interactions are more polar than protein cores (69)
and require the desolvation of polar atoms to be offset by an interface spanning hydrogen bond
(70). A transient interaction requires the proteins involved to be stable in both the bound
and unbound state. Mutations that favor an interaction could cause one of the monomers to
become unstable and aggregate. Monomeric proteins only need to be designed in the context of
the final folded structure (53; 71). Buried water molecules can bridge hydrogen bonds between
molecules and stabilize the complex (72). So far, attempts to model water mediated hydrogen
bonds have not yielded encouraging results (73). Electrostatic complementation is another
driving force behind protein-protein interaction (70; 74). Optimizing long range electrostatic
steering can enhance the affinity of an interaction by increasing the on rate (kon) (75; 76).
Though useful, intensive electrostatics calculations are impractical during design because of
speed and the need for a pairwise additive potential (28). A survey of successful and failed
protein interface designs revealed that electrostatic complementation was not designed in most
computational models (64). Recent advances in simplifying electrostatic models could allow
their incorporation into design simulations (77).
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Many groups have employed specialized energy functions to redesign protein-protein inter-
actions for altered specificity or increased affinity. The requirement for specialized interface
potentials should not be necessary, although different residues are preferred in interfaces versus
proteins as a whole (69) the same packing density and hydrogen bond geometry is observed
in monomers and across protein interfaces (78). The results of these studies have provided
no consistent insight into energy function improvements. Different studies found success by
increasing the weight of interchain interactions (35), down weighting the solvation terms of
the energy function (68; 79), specifically favoring the electrostatic component of the energy
function (37), and training the energy function on mutational data for a specific interface (67).
The need for modified energy functions for protein interfaces is more likely to be indicative of
a flaw in design methodology and sampling than in the energy function.
The research highlighted here suggests that one hurdle to computational interface design
is the correct modeling of hydrogen bonds and electrostatics. It is imperative to devise new
strategies that can overcome this and other persistent complications faced in computational
protein-protein interaction design. The successes and failures of interface design can also be
examined to glean any information that indicates why many designs fail and only few succeed.
1.4 Using β-strands for protein-protein interface design
“Stealing” the sequence information or local structure from natural protein-protein inter-
faces is a prudent way to design a new interactions or inhibit existing ones. (80). It allows
us to borrow information from the billions of years life has spent engineering interactions and
reapply it for our needs. Nature uses a variety of different motifs, folds, and sequences to form
the basis of a protein-protein interface (81). One common interface architectural motif is pair-
ing solvent accessible β-strands to form an intermolecular β-sheet (Figure 1.1). These paired
β-strands form hydrogen bonds between the main chain atoms in a antiparallel orientation
(82). Remaut and Waksman (83) surveyed heterodimeric protein interactions that result in
an intermolecular β-sheet and determined that these occur through either β-strand addition
(Figure 1.2A), β-strand fold completion (Figure 1.2B), or β-strand zippers. Proteins in the
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Ras family form a complex with their ubiquitin-like effectors via an intermolecular β-sheet
(84) (Figure 1.2C). Antiparallel cross-chain β-strand pairing also represents 8.8% of contacts
observed in homodimeric proteins (Figure 1.2D) (82). Paired β-strands in homodimers are
often longer than those involved in forming hetero-complexes (85).
Target 
Protein! Scaffold 
Protein!
Figure 1.1: Model of heterodimer β-strand interaction. A target protein (blue) with an
exposed β-strand forming a complex with another scaffold protein (red) with an exposed
strand. Black dashed lines represent main chain hydrogen bonds formed across the interface.
Interface design based on β-strand pairing presents a solution to two problems in compu-
tational protein interface design: assuring orientation specificity and satisfying hydrogen bond
potential. β-strand interactions are geometrically constrained by hydrogen bonding between
the main chain atoms and the twist and sheer observed in β-sheets has been well documented
(90; 91; 92). This specificity for a particular hydrogen bonds arrangement should prevent the
formation of a complex that does not match the design model (66). Complementary strand
pairing across an interface helps satisfy some of the hydrogen bond potential without the need
for sequence design. Design can then proceed from well established side-chain preferences for
β-sheet formation and stability (93; 94; 95; 96).
The intrinsic potential of exposed β-strands to self-assemble makes them an attractive
starting point for interface design. β-strands are often called sticky because of their tendency
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A! B!
C! D!
Figure 1.2: Natural β-strand mediated protein interactions. A) Crystal structure of thymine
DNA glycosylase (light blue) conjugated to SUMO-1 (grey) (PDB ID: 1WYW) demonstrating
β-strand addition(86). B) Crystal structure of the chaperone protein PapD (beige) in complex
with PapK (purple) (PDB ID: 1PDK) demonstrating fold completion (87). C) Canonical β-
strand mediated GTPase-effector interaction demonstrated by the complex of RAP1A (blue)
with c-Raf1(red) (PDB ID: 1GUA) (88) D) Symmetric homodimer molybdopterin synthase
(PDB ID: 1NVJ) with anti parellel β-strands at the interface between the two chains (green
and orange) (89).
to interact with other strands. This is evident in β-strand pairing in crystal contacts (97; 98; 99;
53) and the propensity of β-sheet proteins to uncontrollably assemble into amyloid-like fibrils
(100; 101). Exposed strands are so prone to interact with each other that nature uses negative
design elements such as strand kinks, charged residues, or occlusion with a loop to prevent
nonspecific β-strand interactions (102) Solvent accessible strands that interact with another
protein tend to be longer and have fewer negative design elements than their counterparts
(102; 85). The strength of β-strand interactions makes it possible to eliminate whole strands
from the center of a β-meander motif and still maintain solubility and overall fold topology
(103; 104). The potential downfall of this approach is that any mutations along an exposed
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strand could cause the designed protein to uncontrollably self assemble. While this is a distinct
possibility, explicit negative design steps were not required to redesign a natural β-sandwich
protein (71), which suggests negative design elements exist in the backbone of exposed strands.
Several studies have shown the efficacy of using β-strands to alter protein function. Cyclic
peptide inhibitors of protein-protein interactions and protease activity are thought to bind to
their targets via formation of a intermolecular β-sheet (105; 106). Directed evolution experi-
ments have generated β-strand pairing between an antibody and its antigen (107) as well as
phage display targets with an exposed strand (108). Amyloid fibrillization can be inhibited by
a peptide designed to form a terminating β-strand on a growing fibril (109) and an evolved
β-strand presenting protein (110).
The following chapters seek to provide a solution to some of the difficulties in protein-
protein interaction design. First, I introduce β-strand pairing at protein-protein interfaces as
a way to ensure orientation and affinity at a de novo interface. I demonstrate that pairing
solvent exposed β-strands, followed by sequence design at the interface, can lead to the accurate
design of a symmetric homodimer in Chapter 2, beginning on page 22. Chapter 3 (page 52),
extends this idea to the design of a binder to a natural protein using β-strand pairing at
the targeted interface. I describe a general method to find proteins capable of forming an
intermolecular β-sheet. Finally, Chapter 4 (page 77) examines successful and failed attempts
to computationally design novel interfaces and finds that most successful designs have few
designed polar interactions at the interface.
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Chapter 2
Computational design of a symmetric
homodimer using β-strand assembly
The work in this chapter has been published in Proceedings of the National Academy
of Sciences (2011) 108: pp 20562-7. (1). Mike Miley helped up screening conditions for
crystallography and screened crystals for diffraction. Mischa Machius collected the X-ray
diffraction data and helped determine the structure. Ashutosh Tripathy designed the AUC
experiments to measure affinity and size of the protein constructs.
2.1 Introduction
Protein-protein interactions and assemblies are essential for a wide array of cellular pro-
cesses. The ability to rationally design unique protein interactions could provide scaffolds
for functional reactions and new reagents for perturbing and monitoring cellular processes.
Computational approaches for interface design have advanced rapidly in recent years and have
allowed interactions to be engineered for increased affinity or altered specificity (2; 3). One
long-standing goal is the creation of unique interactions. Thus far, most computational designs
of new interactions have involved either the pairing of α-helices (4; 5; 6; 7) or binding of an α-
helix to an open groove on a target (8; 9; 10; 11). Other methodologies have focused on grafting
side-chain interactions from a known interaction onto another scaffold (8; 12; 13). There have
been two examples of structurally confirmed unique computational interface designs (7; 8),
however these sample a limited set of modes by which proteins can interact. New methods
of constructing an interface are necessary to mimic the ways nature forms protein-protein
interactions (14).
There are many examples of naturally occurring protein heterodimers, homodimers, and
larger complexes where β-strands from each chain associate to form an intermolecular β-sheet
(15); β-strand pairing has also been observed in evolved antibody-antigen interactions (16) and
monobody-target interfaces selected from phage display libraries (17). It has been proposed
that β-strand pairing is so favorable that naturally occurring proteins often use negative design
to avoid edge-to-edge association. In one study, 75 monomeric β-sheet proteins were visually
examined to see if they contained structural features that would be predicted to disfavor β-
sheet formation across their edge strands (18). In almost every case, one or more negative
design elements were present including prolines, strategically placed charges, very short edge
strands, loop coverage, and irregular edge strands. The propensity of exposed β-strands to
pair is reinforced by observations of intermolecular β-sheet formation at crystal contacts of
crystallization chaperones (19; 20) and designed proteins (21; 22) with exposed strands. In
addition to providing affinity, β-strand interactions are geometrically constrained (23), which
could provide a stable building block for designing interactions with a predetermined binding
orientation. The intrinsic preference of β-strands to interact suggests that they may serve as
a good anchor point for de novo interface design.
Formation of symmetric homodimers is one of the most common ways that proteins interact
(24). Symmetric oligomerization provides increased stability, strict control over the number of
protein units in the assembly, and low-energy structures (25). A survey of secondary structure
at interfaces found that strand pairing represents 8.8% of contacts in homodimers (15). Paired
β-strands at a homodimer interface are typically antiparallel (15) and longer than noninterface
forming exposed strands (26). Protecting elements, typical of exposed strands in monomeric
proteins, are less prevalent at β-strand mediated protein interfaces (18; 26).
There have been few successful rational designs of β-strand mediated protein interac-
tions. Peptides that form β-strand mimetics are therapeutically used to inhibit proteases or
protein-protein interactions(27; 28). One approach targeted amyloid fibrils by computationally
designing a peptide to form a terminating β-strand on a growing fibril (29). Another study
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took the sequence of the β-strand of a known β-strand mediated homodimer and embedded
it in a cyclic peptide (30). A crystal structure of the peptide showed it formed an antiparallel
β-strand paired dimer as predicted (31). However, there have been no structurally verified
computational designs of a unique protein-protein interaction between two domains where the
interface contains interactions between β-strands.
Here, we redesign a monomeric protein to form a symmetric homodimer via an intermolec-
ular β-sheet. To design a β-strand mediated homodimer, we first identified structures in the
protein database with exposed β-strands that could self-associate by β-strand pairing. We
then used symmetric docking and sequence optimization (32) to create favorable interactions
surrounding the interacting strands. Four designs were experimentally characterized and one
was found to adopt the structure of the computational model.
2.2 Materials and Methods
2.2.1 Search Method for Homodimer Scaffolds
To find possible starting structures for homodimer design, we computationally scanned
through a set of 5,500 high-resolution crystal structures. All computational steps were per-
formed in the Rosetta3 suite of macromolecular protein modeling software (33). We defined a
β-strand as surface-exposed if it met three criteria: (i) five sequential residues had β-strand
secondary structure as judged by the Database of Secondary Structure of Proteins algorithm
(34); (ii) there were no backbone-backbone hydrogen bonds formed by every other residue in
the strand; and (iii) every other residue had fewer than 16 neighboring residues, or had 16-30
neighbors and a SASA per atom greater than 2.0 A˚2. Residues are defined as neighbors if their
Cβ to Cβ distance is < 10 A˚. An example command line used to find the exposed strands
follows:
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./exposed_strand_finder.<exe>
-database <rosetta_database>
-l <list_of_inputs>
-ignore_unrecognized_res true
-packing::pack_missing_sidechains
-out::nooutput > exposed_list
We then created a potential homodimer. The axis of an exposed β-strand was defined
as a vector from the Cα atom on the first residue of the strand to the Cα atom on the final
residue of the strand. Another vector is defined at the center residue of the strand from
the carbonyl carbon to carbonyl oxygen. A final vector is drawn perpendicular to the two
vectors described through the Cα atom of the residue at center of the strand. The antiparallel
homodimer is constructed by copying the protein and rotating the copy 180◦ about this axis.
The copied chain is then translated away from the original by 6.0 A˚ to create a starting point
for evaluation. The copied chain was then translated along the axis of the exposed strand
in steps of 7 A˚ to identify alternate conformations that have no clashing backbone atoms.
As a final filter, we check to make sure there are no backbone-backbone clashes between the
two chains. The identification of exposed β-strands generated from the above protocol was
used as input for the next step. The command line used to make potential homodimers with
interacting strands of five residues was
./homodimer_maker.<exe>
-database <rosetta_database>
-s <pdb_file>
-run::chain <chain_char>
-sheet_start <start_residue_#>
-sheet_stop <last_residue_#>
-window_size 5
To narrow down the list of alignments, we ran short symmetric design simulations followed
by side-chain and backbone minimization. These alignments were then filtered for designs that
possessed an interface area of at least 850 A˚2, two or fewer polar atoms not forming hydrogen
bonds at the interface, and a calculated ∆Gbind of less than -15.0 Rosetta energy units. The
protocol used for this step is similar to the one for full design below.
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2.2.2 Homodimer Design and Selection
The computational homodimer interface design strategy is similar to the Dock Design
Minimize Interface protocol used previously for heterodimer design (10). Each step employed
Rosettas symmetry protocols, which can perform symmetric protein-protein docking, symmet-
ric design, and side-chain/backbone minimization (32; 35). The homodimer model generated
above was used to generate the symmetry definition and starting structure for interface de-
sign. First, the protein is symmetrically docked against itself to sample rigid-body degrees of
freedom. After the docking step, all residues within 8 A˚ of the other chain were symmetrically
designed. Finally, the backbone and side chains of all interface residues were minimized. An
example command line for this protocol is:
./homodimer_design.<exe>
-database <rosetta_database>
-s <pdb_file>
-symmetry:symmetry_definition <symmdef>
-nstruct 5000
-pack_min_runs 4
-make_ala_interface false
-find_bb_hbond_E true
-no_his_his_pairE true
-disallow_res CGP
-use_input_sc -ex1 -ex2
-docking:docking_local_refine true
-docking:sc_min true
-docking:dock_ppk false
-symmetry:perturb_rigid_body_dofs 3 5
-out:file:fullatom
2.2.3 Evaluation of Designs
We selected which computational designs to express based on several metrics. As a first
criterion, we selected designs that were in the top 10% in backbone-backbone hydrogen-bond
energy across the interface, total Rosetta energy, and calculated ∆Gbind. We then calculated
additional metrics including interface energy density (∆Gbind/∆SASA ), RosettaHoles score
(36), and number of buried-unsatisfied at the interface. To pick out the final designs to test
experimentally, we visually inspected the designs that scored better than native interfaces in
all of these metrics.
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2.2.4 DNA Construct and Protein Production
DNA sequences for the wild type and all four designs were synthesized by GenScript
USA and cloned into the pQE-80L vector as 6-His-maltose-binding protein (MBP) fusions as
described previously (10). All proteins were expressed in BL21(DE3) pLysS cells induced with
0.3 mM IPTG overnight at 18 ◦C. The proteins were purified by immobilized-nickel affinity
chromatography and then cleaved from 6-His-MBP with tobacco etch virus protease. The
cleaved proteins were again subjected to immobilized-nickel affinity chromatography to trap
the 6-His-MBP. Flow-through from the nickel column was then further purified with size-
exclusion chromatography (Superdex 75) in buffer A (20 mM MES, pH 6.0, and 150 mM
NaCl). Protein concentration was quantified based on absorbance and a predicted extinction
coefficient (ExPASy; ProtParam) of 8;480 M−1 cm−1 for wild type and βdimer4, 13;980 M−1
cm−1 for βdimer1, 12;490 M1 cm1 for βdimer2, and 9;970 M−1 cm−1 for βdimer3.
2.2.5 Multiangle Light Scattering
Samples of βdimer1, βdimer3, and the wild-type protein were concentrated to approxi-
mately 300 µM (4 mg/mL) in buffer A and injected onto a WTC-030S5 size-exclusion column
(Wyatt Technologies) connected to a multiangle light scattering instrument (DAWN HELEOS
II; Wyatt Technologies) and a refractometer (OPTILAB rEX; Wyatt Technologies). Molecular
mass of particles in a single elution peak was calculated based light scattering data using the
ASTRA software package (Wyatt Technologies).
2.2.6 Analytical Ultracentrifugation Sedimentation Equilibrium
Sedimentation equilibrium experiments were performed using a Beckman XL-I analytical
ultracentrifuge using six-sector cells and an An-50 Ti rotor. Samples of wild-type protein,
βdimer1, and βdimerdimer3, at concentrations of 20, 40, and 60 µM in buffer A, were spun
at 46,400 g until equilibrium was reached. Absorbance measurements at 280 nm were taken
every 2 h. The absorbance offset was found by meniscus depletion after spinning the samples
at 163,300 g for 6 h. The sedimentation equilibrium data were analyzed with XL-I data
analysis software.
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The homodimer dissociation constant was measured in a similar fashion to the method
outlined above. βdimer1 was placed at in the sample cells at concentrations of 0.8, 1.5, and
2.0 µM in 20 mM KH2PO4, pH 7.0 and 150 mM NaCl. The absorbance was measured at 215
nm to obtain readings sufficiently above background to reliably fit the data. The data were
analyzed using a monomer-dimer equilibrium model.
2.2.7 Fluorescence Polarization Assay
A variant of βdimer1 with the mutation S62C was produced for labeling with thiol reactive
Bodipy (507/545)-iodoacetamide (Molecular Probes). The labeling procedure was performed
as previously described (10). Buffer A supplemented with 5 mM β-mercaptoethanol was
used as the binding buffer for the titrations. Bodipy-labeled βdimer1, at a concentration
of 2 nM, was placed in a 1-cm path length cuvette and titrated with unlabeled protein. The
change in fluorescence polarization was measured using a Jobin Yvon Horiba Spex FluoroLog-3
instrument (Jobin Yvon, Inc.). Titration amounts were calculated as described in Appendix A
on page 129.The data were analyzed according to a homodimerization model (described below)
and fit with Prism (GraphPad Software).
2.2.8 Homodimerization Fluorescence Polarization Fitting Procedure
We derived a homodimerization model to be used when fitting the fluorescence polarization
data. This model accounts for the interaction of a protein A with itself in its labeled (A∗) and
unlabeled states (A). The model was derived as follows where P is the total amount of protein
in a given state:
A+A
 AA
A∗ +A
 AA+A∗A∗ +A∗A+AA∗
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Writing this in terms of Kd and total protein concentration:
Kd =
[A]2
[AA]
[Ptotal] = [A
∗
total] + [Atotal]
[Pmonomer] = [A
∗
monomer] + [Amonomer]
[Pdimer] = [A
∗A∗] + [A∗A] + [AA∗] + [AA]
[Pdimer] =
[Ptotal]− [Pmonomer]
2
Solving for the total concentration of monomeric protein gives:
[Pmonomer] =
−Kd +
√
K2d + 8[Ptotal]Kd
4
Any change in signal seen would come from association of a labeled and unlabeled protein. We
assume that the interactions between labeled and labeled is negligible because labeled protein
is present in low concentrations.
[A∗A] = [AA∗] = [Pdimer]
[A∗total] + [Atotal]
[Ptotal]
This model is then written to fit the change in polarization:
Polobs = (Polmax − Polmin) [A
∗A] + [AA∗]
[Atotal]
− Polmin
The code for this fit is given in Appendix A on page 129.
2.2.9 Crystallization and Structure Refinement
Crystallization of βdimer1 was performed using the hanging-drop vapor diffusion method
at 20 ◦C. Crystals formed after one week in a drop consisting of 2 µL of βdimer1 (7 mg/mL in
buffer A) and 1 µL of well solution [100 mM sodium acetate, pH 5.0, 6% (vol/vol) isopropanol,
20% (wt/vol) PEG 8000]. Prior to data collection, crystals were cryoprotected by transferring
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them into well solution supplemented with 15% (vol/vol) ethylene glycol before plunging them
into liquid nitrogen. The crystals diffracted X-rays to a minimum Bragg spacing of about
1.0 A˚, exhibited the symmetry of space group P21 with cell parameters of a = 50.6 A˚, b =
44.3 A˚, c = 53.0 A˚, β= 91.91◦, and contained two molecules in the asymmetric unit (solvent
content, 44%). Diffraction data were collected at 100 K at a wavelength of 0.91840 A˚ at the
Advanced Proton Source General Medicine and Cancer institutes Collaborative Access Team
23IDB beamline. The diffraction data were indexed and reduced using HKL2000 (37).
The structure of βdimer1 was determined by molecular replacement using the program
Phaser (38); the computationally designed dimer of βdimer1 was used as a search model.
Iterative rounds of refinement were conducted with REFMAC (39) and PHENIX (40), inter-
spersed with manual adjustments to the model using the program Coot (41). The final model
contains two molecules in the asymmetric unit with all residues defined in the electron density,
except for residues 23-26 in both molecules.
2.3 Results
2.3.1 Scaffold Search Protocol
To find proteins with surface-exposed β-strands, we performed a computational search on
a set of 5,500 protein crystal structures with resolution better than 2.2 A˚ to find proteins
with a surface-exposed β-strands (Figure 2.1). A strand was defined as exposed if there was
a continuous stretch of five or more residues in which every second residue did not form
backbone-backbone hydrogen bonds and were not occluded from solvent (see Materials and
Methods). This criterion yielded 1,500 exposed β-strands on 1,100 unique proteins. We then
tested each exposed β-strand for its potential to form the basis of a homodimer interface. A
copy of the entire chain of each protein with an exposed strand was rotated and translated to
an ideal backbone-backbone hydrogen bonding distance to the original protein chain (Figure
2.1). The copied chain was then translated along the exposed strand in steps of 7 A˚ to identify
alternate conformations that had no clashing backbone atoms. After this step, there were
2,800 potential alignments of 900 different proteins.
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Figure 2.1: Search and design protocol for a symmetric β-strand mediated homodimer.
Method used to search for, then design, scaffold proteins to create a symmetric homodimer
(see full details in Materials and Methods). Numbers in parentheses represent the total number
of unique input structures used in each step. Individual steps are illustrated by the structures
generated during each step using the protein Atx1 (Protein Data Bank ID 1CC8).
To narrow down the list further, we performed a brief design and minimization protocol
to determine which of our potential homodimers gave favorable binding energies and interface
sizes after design (see Materials and Methods). This step reduced the overall number of
targets to 200. From the final set of designable alignments, we removed all proteins that had
not previously been expressed in Escherichia coli, were natural oligomers, had crystal contacts
that resulted in an intermolecular β-sheet, were over 500 amino acids in length, or whose
interacting β-strands were not part of globular domains. These steps generated 50 possible
starting points for design of a homodimer.
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2.3.2 Design Protocol
Each design simulation consisted of one round of symmetric protein docking (35) followed
by five successive rounds of symmetric sequence optimization and minimization of side-chain
and backbone residues at the homodimer interface (see Materials and Methods). For some
protein scaffolds it was necessary to build alanine into all positions at the interface to obtain a
docked structure that formed hydrogen bonds between the β-strands. We applied a stringent
filter to eliminate designs that were unlikely to produce the desired experimental results.
First, from each run, we selected only designs in the top 10% in total score, ∆Gbind, and
β-strand hydrogen-bond energy. These selections were further filtered for interface energy
density (∆Gbind/SASA, where SASA represents the solvent-accessible surface area), number
of buried polar atoms failing to form hydrogen bonds, and packing quality (RosettaHoles
score) (36). We selected four homodimer designs based on the γ-adaptin appendage domain
(Protein Data Bank ID 2A7B) (42). This scaffold protein was chosen because the designs
of 2A7B scored favorably compared to other potential homodimers according to all metrics
described above. Two of the four designs chosen had predominantly hydrophobic interfaces
(βdimer1 and βdimer2), whereas the other two contained more polar interactions (βdimer3
and βdimer4) (Table 2.1), which allowed us to test our ability to design hydrogen bonding
networks and hydrophobic packing interactions. All four designs exhibited a similar overall
conformation and β-strand register to that of βdimer1 (Figure 2.2A). The maximum Cα rmsd
from βdimer2, βdimer3, and βdimer4 to βdimer1 is 1.5 A˚. All four designs have a total of
six main-chain hydrogen bonds between residues 104, 106, and 108 on one chain to residues
108, 106, and 104 on the other chain, respectively. One face of the intermolecular β-sheet is
exposed to solvent, whereas the other is occluded by a loop formed by residues 10-12. The
crystal structure 2A7B has no crystal lattice contacts along the exposed strand, suggesting
that the wild-type sequence is not prone to form an intermolecular β-sheet. Wild-type -adaptin
appendage domain is likely prevented from self-association by a salt bridge between residues
K10 and D107 that would be buried at the designed homodimer interface. In the designs,
K10 is mutated to alanine, leucine, or serine and D107 is mutated to serine or threonine. A
common feature in all four designs is charge complementation on the solvent-accessible side
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of the interacting strands between residues 104 and 108 on opposite chains. For example, in
βdimer1, residue 104 is a lysine and residue 108 is a glutamate. In βdimer3, residue 104 is
an arginine and residue 108 is a glutamate. The buried side of the interface is dominated
by either hydrophobic or polar interactions depending on the design (Figure 2.2 B-E). A
search of Protein Data Bank Protein Interfaces, Surfaces, and Assemblies (43) yielded no
known interfaces bearing any similarity to the designs, suggesting that the designed complexes
represent a unique configuration of a protein-protein interaction.
Model No. mutations Etotal ∆Gbind No. buried-unsatisfied Polar interface area, %
Wild type 0 -561 -13 8 48
βdimer1 11 -597 -29 2 39
βdimer2 7 -593 -30 0 31
βdimer3 5 -596 -32 0 54
βdimer4 9 -593 -27 0 46
Table 2.1: Computational evaluation of designed homodimer models . Computational values
used to select homodimer designs are shown compared to the wild-type protein represented as
a homodimer forced into a conformation similar to the designs. No. mutations is the number
of mutations to the wild type to generate the design, Etotal is the Rosetta energy for the
homodimer, ∆Gbind is the difference in energy between the complex and two monomers of a
model (∆Gbind= EAB − EA − EB), No. buried-unsatisfied is the number of polar atoms that
are not solvent accessible and do not form hydrogen bonds to another atom in the protein,
and Polar interface area, % represents the amount of solvent-accessible surface area of polar
atoms hidden at the interface (SASApolar/SASAtotal).
2.3.3 Determining Oligomeric Status
We first assessed the oligomeric state of the four designs and the wild-type protein by size-
exclusion chromatography. The molecular mass of a monomeric protein based on sequence is
13.5 kDa. The wild type, βdimer3, and βdimer4 eluted near the expected molecular mass for
a monomeric protein, whereas βdimer1 and βdimer2 eluted close to the size expected for a
dimer (Figure 2.3A and Table 2.2). We were unable to perform additional experiments with
βdimer2 and βdimer4 because they did not express at sufficient levels.
To confirm the results from size-exclusion, we performed sedimentation equilibrium ex-
periments using a Beckman XL-I analytical ultracentrifuge (AUC-SE). The wild-type protein,
βdimer1, and βdimer3 were spun at 46,400 ×g until equilibrium was reached. Three concen-
trations of protein (20, 40, and 60 µM) were used for each sample. Equilibrium absorbance
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Figure 2.2: Computational designs used in experiments. (A) Overall topology of computa-
tional designs. The γ-adaptin appendage domain (Protein Data Bank ID 2A7B) is used as
the scaffold for the designed interface. Coloring (purple and green) highlights the symmetric
chains in the model. The solvent-excluded side of the interface is shown in detail for βdimer1
(B), βdimer2 (C), βdimer3 (D), and βdimer4 (E). Selected side chains are shown in sticks.
Black dashed lines represent hydrogen bonds at the interface; the six main-chain hydrogen
bonds are not shown.
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profiles at 280 nm were used to determine molecular mass. The profiles for all three proteins
were well fit by a single species model (Figure S2.1). The molecular mass determined from
the equilibrium profile of the wild-type protein and βdimer3 were 12 and 16 kDa, respectively,
close to that expected for a monomer. The molecular mass of βdimer1 was found by the same
method to be 26 kDa, near that expected for a homodimer (Table 2.2).
We further tested the solution molecular mass of βdimer1, βdimer3, and the wild-type pro-
tein by size-exclusion chromatography (SEC) followed by multiangle light scattering (MALS).
Each protein came off the size-exclusion column as a single peak. Light scattering and refrac-
tive index were used to determine the molecular mass of the peak (Figure 2.3B). The results
were similar to the SEC experiment described above. βdimer3 and the wild-type protein were
determined to have a molecular mass of 13 kDa, whereas βdimer1 had a molecular mass of 26
kDa (Table 2.2). These results further confirmed that βdimer1 forms a homodimer, but the
wild type and βdimer3 do not.
2.3.4 Homodimer Binding Affinity
We used a fluorescence polarization assay to measure the dimer dissociation constant of
βdimer1. Briefly, we expressed βdimer1 with the mutation S62C and labeled it with thiol
reactive Bodipy. The monomer-dimer equilibrium was monitored by titrating excess unlabeled
protein into dilute, Bodipy-labeled, βdimer1 protein and observing the increase in polarization
from the formation of a slowly rotating dimeric species. βdimer1 was titrated with wild-type
protein as a control. The change in polarization upon binding was fit to a homodimerization
Molecular mass, kDa
Protein Monomer (calculated) SEC AUC SEC/MALS
Wild type 13.6 11 12 13
βdimer1 13.6 26 26 26
βdimer2 13.7 21 – –
βdimer3 13.7 10 16 13
βdimer4 13.6 12 – –
Table 2.2: The molecular mass in solution measured for the wild-type protein and homodimer
designs measured with using SEC, AUC, and MALS. Monomer (calculated) is the molecular
mass expected based on sequence. The βdimer2 and βdimer4 proteins did not express in
significant quantities for additional molecular mass determination.
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Figure 2.3: Experimental determination of molecular mass in solution. (A) Size-exclusion
chromatography (Superdex 75) of the designs and wild-type protein. Absorbance has been
normalized based on maximum value, the apparent molecular mass (MM) is based on a stan-
dard curve obtained from globular proteins. (B) Size-exclusion chromatography (Superdex
75) followed by multiangle light scattering of wild type (gray) and βdimer1 (black). Rayleigh
ratio [R(θ)] (solid lines) has been normalized based on maximum value; MM (open circles) is
calculated from light scattering and refractive index. The average molecular mass is 26 kDa
for βdimer1, 14 kDa for the wild type. (C) Measurement of dimer dissociation constant of
βdimer1 using a fluorescence polarization assay. Bodipy-labeled βdimer1 was titrated with
unlabeled βdimer1 (black) and wild-type protein (gray), and the change in polarization was
fit to a homodimerization model (see SI Materials and Methods). The calculated homodimer
dissociation constant for βdimer1 is 1.0± 0.1 µM (SEM).
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model (Materials and Methods). βdimer1 had a dimer dissociation constant of 1.0 µM, whereas
the wild-type protein showed little to no interaction with βdimer1 (Figure 2.3C). To confirm
this result, we performed AUC-SE with βdimer1 at concentrations of 0.8, 1.5, and 2.0 µM. The
data were fit to a monomer-dimer self-association model that produced a dimer dissociation
constant of 0.96 µM (Figure S2.2), which closely matches the dissociation constant determined
by fluorescence polarization.
2.3.5 Crystal Structure of the βdimer1
We determined the crystal structure of βdimer1 using molecular replacement and diffrac-
tion data to a resolution of 1.09 A˚ (Table S2.1). The coordinates of the dimer design were used
as the search model for molecular replacement. The asymmetric unit contained two molecules
of βdimer1 protein, henceforth called chain A and chain B. These two chains in the crystal
structure interact in a manner that is remarkably similar to the model of βdimer1 (Figure 2.4A)
with an rmsd between the crystal structure and model of 1.0 A˚ for all backbone atoms. The
intermolecular β-strand pairing found at the interface between the two chains in the crystal
structure matches that of the designed model (Figure 2.4B). The conformation of the inter-
acting strands in the crystal structure of βdimer1 show only minor differences when compared
to the wild-type protein (Figure S2.3), indicating that substantial backbone rearrangement is
not required for the formation of the homodimer.
The conformations of the interface residues in the crystal structure were well predicted
by the computational model (Figure 2.4C). The conformations of the designed hydrophobic
side chains in the crystal structure closely match those of the designed structure including
L11 from one chain packing between L11 and W100 from the other chain. The computational
model also accurately predicted an interface-spanning hydrogen bond between the backbone
nitrogen of D9 and the hydroxyl oxygen on Y103 (Figure 2.4C). The solvent-exposed side
of the paired strands presents an interesting divergence from the model. The side chains of
residues E108 and Q106 appear to form hydrogen bonds from the side-chain nitrogen on Q106
to a carboxyl oxygen on E108, and from the other carboxyl oxygen on E108 to the side-
chain oxygen on Q106 (Figure S2.4), suggesting the carboxyl group of E108 is protonated.
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Figure 2.4: Comparison of βdimer1 computational model to crystal structure. (A) Overlay
of the βdimer1 computational model (green and purple) and crystal structure (cyan). The
backbone atom rmsd for the entire structure is 1.0 A˚. (B) Backbone-backbone interactions
between the interface-forming β-strands viewed from the solvent-accessible side of the inter-
molecular β-sheet. The 2Fo − Fc electron density (gray) is contoured to 2σ. (C) Detailed
view of designed side chains forming interactions on the solvent-excluded side of interacting
β-strands. A black dashed line represents the interface-spanning hydrogen-bond between D9
and Y103
.
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Unmodeled protonated glutamates have also been observed forming stabilizing interactions in
a computationally designed loop (44).
One possible pitfall of using β-strands to mediate an interaction is the possibility for
register shifts between the paired strands. It is interesting to consider what structural elements
in βdimer1 set the register between the two proteins. Docking the chains with constraints to
force a register shift in either direction yielded no models with backbone-backbone hydrogen
bonds at the interface. A shift in one direction introduces a clash between the side chains and
backbone atoms of L11 in both chains, whereas a shift in the opposite direction creates a clash
between residues Y8 and L11 on one chain with Y103 on the interacting chain (Figure S2.5).
2.4 Discussion
Our results demonstrate that protein-protein interactions can be engineered by selecting
protein scaffolds with complementary, surface-exposed β-strands, then computationally de-
signing the interface residues to form favorable interactions. One of the four homodimers
we designed formed a stable dimer in solution. The crystal structure of this protein closely
matches the design model.
We intentionally selected designs where the intermolecular interactions, other than the
paired β-strands, were either predominantly polar or predominantly nonpolar. Although the
energy and metric scores for these interfaces were similar (Table 2.1), only the designs with
predominantly hydrophobic interfaces formed dimers in solution (Table 2.2). These results are
unsurprising given previous observations that homodimeric interfaces are more hydrophobic
than heterodimeric interfaces (45) and that new hydrogen-bond networks are difficult to design
(46). A closer inspection of the computational model of βdimer3 revealed that four interface-
spanning hydrogen bonds, between designed side chains and backbone atoms, were suboptimal.
The N-H bond vector from the hydrogen-bond donors was more than 60◦ out of plane with the
lone-pair electrons on the acceptor carbonyl oxygens. The N-H bond vector is typically in plane
with the accepting electrons in crystal structures of natural proteins (47). This deviation is not
penalized in the current implementation of the hydrogen-bond energy evaluation in Rosetta.
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Some previous attempts at computational protein interface design have been plagued by
problems controlling binding orientation, including a complete 180◦ rotation from the design
model (48) or existence of multiple low-energy binding conformations (10). The β-strand pair-
ing addresses these issues by constraining the possible geometry of the interface, as illustrated
by the high similarity between the computational model and experimentally determined struc-
ture of βdimer1. One challenge of the β-strand pairing approach is that the paired strands
must have complementary curvatures in order to form low-energy hydrogen bonds across the
interface. This requirement limits the number of naturally occurring proteins that can be
redesigned to form new homo- or heterodimers. One potential way to escape this limitation
is by designing de novo scaffolds that have edge strands with the appropriate curvature for a
target interaction.
Homodimerization illustrates an important step in protein evolution. Many protein-protein
interfaces are built on the progression from a monomer to symmetric homodimer to asymmetric
homodimer to heterodimer (25; 49). In fact, the majority of protein interfaces common across
the three kingdoms of life are symmetric homodimers (24). Our results demonstrate that it is
possible to make the first step in this process without disturbing the backbone conformation
of the monomer. A logical next step in this path is to redesign the interface of the constructed
homodimer to form a heterodimer.
The method of finding complementary, surface-exposed, β-strands presented here could be
extended to other aspects of protein design. This protocol could be used to design a protein to
bind a natural protein with an exposed β-strand, or build higher order oligomeric structures.
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2.5 Supporting Information
Figure S2.1: Determination of molecular mass of wild type, βdimer1, and βdimer3 by an-
alytical ultracentrifugation sedimentation equilibrium. A single-species model was fit to the
data for the wild-type protein, βdimer1, and βdimer3. Data from all three concentrations (20,
40, and 60 µM) were used in fitting to find the molecular mass. The molecular mass was 12
kDa for the wild type, 26 kDa for βdimer1, and 16 kDa for βdimer3.
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Figure S2.2: Determination of βdimer1 dimer dissociation constant by analytical ultracen-
trifugation sedimentation equilibrium. Absorbance was measured at 215 nm for βdimer1 at
concentrations of 2.0 (A), 1.5 (B), and 0.8 µM (C). Data from all three concentrations were
pooled and fit according to a self-association model with the molecular mass of the monomer
assumed to be 13,628 Da. The fit produced a Ka of 9.0 in absorbance units, which can be con-
verted to concentration units with the following equation: Ka(M) = Ka(Abs)(l/2). Where
l is the path length (1.2 cm) and the extinction coefficient () is 192,100 M−1 cm−1. The
extinction coefficient at 215 nm was found experimentally by performing serial dilutions of a
known concentration βdimer1, based on absorbance at 280 nm, and measuring the absorbance
at 215 nm. Using this information the dimer association constant of βdimer1 (Ka) is found to
be 1.04× 106M. The dimer dissociation constant is 0.96 µM.
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Figure S2.3: Comparison of interacting β-strands in βdimer1 chain A (cyan) to the wild-type
structure (2A7B, orange). Residues between S103 (Y103 in βdimer1) to A109 are shown in
sticks. Only small perturbations in the backbone are observed. The backbone atom rmsd
between βdimer1 chain A and the wild-type structure is 0.3 A˚ for this range.
Figure S2.4: The crystal structure reveals side-chain interactions between Q106 and E108
on the solvent accessible side of the interacting β-strands in βdimer1 that were not modeled
in the design. The computational model (purple and green) predicts no interaction between
these side chains, whereas the crystal structure (cyan) indicates a head-on pairing of Q106
and E108. Black dashed lines represent hydrogen-bond interactions. It is likely that E108 is
protonated (βdimer1 crystals were grown at pH 5.0). A protonated variant of glutamate was
not considered in the computational design protocol.
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Figure S2.5: Clashes prevent register shift of βdimer1. (A) A register shift of βdimer1 to
make fewer backbone-backbone contacts is prevented by the introduction of clashes of Y8
and L11 on one chain with Y103 on the matching chain. (B) A register shift in the opposite
direction would be disfavored by clashes of L11 on one strand with L11 on the symmetric
strand. These assemblies were made by manually moving one of the chains to the next register
of backbone-backbone hydrogen-bond contacts.
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Figure S2.6: Backbone torsion angles of of interacting strands (residues 103-109) in βdimer1
design (red) the crystal structure 3a7b (chain A blue, chain B purple) and wild type crystal
structure 2a7b (green). A) Ramachandran plot of residues 103-109, individual points labeled
with residue number. B) Euclidian distance in ◦ between the designed model for βdimer1 and
the crystal structures of the wild type (2a7b) and two both chains of crystal structure of the
design (3zy7 A, B).
45
βdimer1
Data collection
Space group P1211
Cell dimensions
a, b, c, A˚ 50.64, 44.25, 53.02
α, β , γ, ◦ 90.00, 91.91, 90.00
Resolution, A˚ 23.14-1.09 (1.10-1.09)*
Rmerge 0.053 (0.331)
I/σ 33.1 (1.9)
Completeness, % 92.6 (44.6)
Redundancy 3.6 (1.8)
Refinement
Resolution, A˚ 23.14-1.09
No. reflections 90,300
Rwork/Rfree 0.159 / 0.181
No. atoms
Protein 2,087
Ligand/ion 22
Water 314
B factors, A˚2
Protein 14.2
Ligand/ion 23.5
Water 24.5
rms deviations
Bond lengths, A˚ 0.011
Bond angles, ◦ 1.421
Ramachandran statistics
Most favored, %/no. 98.2 / 220
Additionally allowed, % /no. 1.8 / 4
Generally allowed, % / no. 0 / 0
Disallowed, %/no. 0 / 0
Table S2.1: Data collection and refinement statistics. *Values in parentheses are for highest-
resolution shell. X-ray coordinates and structure factors have been deposited in the Protein
Data Bank, www.pdb.org (PDB ID: 3ZY7)
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Chapter 3
Computational design of a β-strand
mediated heterodimer
3.1 Introduction
The design of symmetric homodimers (Chapter 2) provides valuable evidence that a par-
ticular method of interface design can produce successful results (1; 2). However, the ultimate
goal of protein-protein interaction design is to engineer binders to natural proteins to alter
function. A fantastic example is the design of two proteins that bind influenza hemagglutinin
and prevent viral entry into cells (3). Additional approaches to interface design are needed to
construct proteins that can bind to the diversity of protein conformations observed in nature
(4). There are no known computational designs of a heterodimer based on β-strand pairing
between the two chains. A method to target exposed β-strands could provide binding partners
to disrupt an array of natural β-strand mediated interactions(Figure 1.2).
We choose two proteins as targets for heterodimer design based on medical relevance and
presence of X-ray crystal structures showing these protein interact with their natural partners
via a β-strand. The first protein that we chose as a target for de novo interface design was Ras-
like GTPase A (RalA). RalA is involved in the regulation of many cellular processes including
cellular junction formation, endocytosis and the exocyst complex (5) and is necessary for Ras
induced oncogenesis (6; 7). RalA interacts with at least two of its natural downstream effectors
Sec5 and Exo84 via formation of an intermolecular β-sheet. Crystal structures of RalA in
complex with the Sec5 Ral binding domain (Sec5) (8) and Exo84 Ral binding domain (Exo84)
(9) demonstrate that the same β-strand of RalA interacts with both effectors (Figure 3.1).
These interfaces, like many other Ras-effector interactions, are further stabilized by hydrogen
bonds and salt bridges while hydrophobic interactions are minimal (10; 11). Ras-effector
interactions have been shown to be amenable to design. Mutating residues at a Ras-effector
interface can alter the specificity of an interaction (12), improve affinity(13), or yield high
affinity interaction to the GDP bound state(14). A protein designed to bind to RalA that is
not involved in the natural signaling pathway could be a tool to further understand its function
and elucidate the many downstream effects of RalA activity.
The second protein chosen as a target was Proprotein convertase subtilisin-like kexin type 9
(PCSK9). PCSK9 is a secreted protein that regulates the presence of Low Density Lipoprotein
receptor (LDLr) on cell surfaces. The interaction between PCSK9 and LDLr leads to degra-
dation of LDLr thus preventing LDLr from regulating LDL levels in the blood (15). Levels
of active PCSK9 have an inverse relationship with the presence of LDLr on cell surfaces and
an direct relationship with the amount of LDL in the blood (16; 17). Humans with a loss of
function mutation in PCSK9 have lower LDL levels and reduced risk of heart disease (18) while
gain of function mutations can lead to hypercholesterolemia (19). PCSK9 binds to EGF hand
motif on LDLr, via an intermolecular β-sheet (Figure 3.2A) (17). An antibody obtained by
phage display interacts with PCSK9 at the same place as LDL (Figure 3.2B). When injected
into monkeys this antibody lowered blood LDL levels by as much as 50% over two weeks (20).
A small protein that binds to PCSK9 in the same manner as the antibody could serve as a
therapeutic protein based drug for high LDL levels.
Yeast surface display is one of the most widely used systems for in vitro evolution and
protein engineering (21). It has been used to identify protein-protein interactions, increase
solubility of a protein, increase affinity of an interaction (reviewed in (22)) and evolve bond
forming enzymes (23). Yeast surface display has been shown to be an efficient method to evolve
a library of protein sequences to bind to a target of interest through successive rounds of FACS
and random mutagenesis (24). It is also possible to measure the affinity of individual clones
(21). Recently, Fleishman et al used yeast surface display to identify and mature the affinity
of two computational protein interface designs to a target (3). Yeast surface display was also
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used to improve the stability and binding affinity of a computationally designed protein that
displays a segment of HIV gp120 (25). These results suggest that yeast display is an efficient
method to characterize and improve β-strand mediated heterodimer designs.
A!
B!
Figure 3.1: RalA forms β-strand mediated interactions to two known effectors. Crystal
structure GTP bound RalA (olive) in complex with A) Sec5 (magenta) (PDB ID: 1UAD) (8)
and B) Exo84 (grey) (PDB ID: 1ZC3) (9)
This chapter discribes one possible approach to finding protein scaffolds capable of binding
to a target protein with an exposed β-strand and designing the scaffolds to interact with a
target protein. First we identify a possible backbone conformation that could bind to a target
protein then search for proteins with an exposed β-strand that matches the desired confor-
mation. The identified scaffold proteins are then docked against the target and redesigned
with Rosetta. Although initial experimental results are not encouraging, the protein scaffolds
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Figure 3.2: PCSK9 forms β-strand mediated interactions to two known binders. A) Crystal
structure of PCSK9 (green) in complex with a domain from its natural effector LDLr (brown)
(PDB ID: 3BPS) (17). B) Crystal structure of an antibody (blue) evolved to bind to and
inhibit PCSK9 activity in complex with PCSK9 (green) (PDB ID: 2XTJ) (20).
found using this protocol are excellent candidates for yeast surface display followed by directed
evolution to obtain a β-strand mediated heterodimer.
3.2 Materials and Methods
3.2.1 Idealized binding strand construction
To construct an idealized binding strand to RalA and PCSK9 a ten residue all alanine
strand with β-strand backbone torsion angles was built along the targeted exposed β-strand of
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both proteins using PyMol. The conformation of RalA was taken from the crystal structure of
RalA in complex with Sec5 (PDB ID: 1UAD) (8). Two different crystal structures were used
for PCSK9, one from the complex of PCSK9 with LDLr (17) and the other from a complex
with an engineered antibody (20) (PDB IDs: 3BPS and 2XTJ respectively). Using Rosetta,
the peptide was docked against its target protein. Conformational space of the peptide was
sampled by making 200 small alterations to the backbone φ and ψ angles followed by energy
minimization. The backbone-backbone hydrogen bond energy was upweighted in the energy
function to favor strand-strand pairing. Residues at the interface on the target protein are
allowed to repack to accommodate the peptide if necessary. A sample command line is as
follows:
./peptide_minimizer.<exe>
-s input_struct.pdb
-database <rosetta_database>
-ncycles 200
-bbhbond_weight_mod 3.0
-nstruct 100
-jd2:ntrials 10
-run::min_type dfpmin_armijo_nonmonotone
-ex1
-ex2
-extrachi_cutoff 1
-use_input_sc true
All of the above command line flags are standard for Rosetta except for ncycles which
controls the number of backbone perturbation steps and bbhbond weight mod which upweights
the backbone-backbone energy by the factor given.
3.2.2 Scaffold search procedure
Suitable scaffolds for design were found by searching a set of 5,200 high resolution (<
2.0 A˚) crystal structures compiled by the Richardson laboratory at Duke University. First,
a potential scaffold examined for surface exposed β-strands based on three criteria (i) five
sequential residues had β-strand secondary structure as judged by the Database of Secondary
Structure of Proteins algorithm (26); (ii) there were no backbone-backbone hydrogen bonds
formed by every other residue in the strand; and (iii) every other residue had fewer than
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16 neighboring residues, or had 16-30 neighbors and a SASA per atom greater than 2.0 A˚2.
Residues are defined as neighbors if their Cβ to Cβ distance is < 10 A˚. A strand that met all
these criteria was then aligned for lowest RMSD to the peptide built onto the exposed strand
of RalA or PCSK9. A scaffold is accepted as a suitable starting conformation for further design
if it has an RMSD to the ideal peptide of < 1.5 A˚ and no backbone clashes with the target
protein. A backbone clash is defined a Lennard-Jones energy greater than 0.0 for cross-chain
backbone atoms. A command line to perform all of these steps is given below:
./exposed_strand_finder.<exe>
-database <rosetta_database>
-l list_of_scaffolds
-native Ral_peptide.pdb
-strand_span B 6 10
-out:nooutput true
-check_rmsd true
-beta_length 5
-max_E_allow 0.0
-max_RMSD 1.5
There are several important command line flags here. First native is the target protein
(RalA in the case above) with the peptide built onto it, the position on that peptide to search
and align against is given by strand span (in this case chain B between residues 6 and 10 in
the structure. Other command line options tell the protocol to do the alignment of an exposed
strand to a peptide strand (check rmsd), define the length of exposed β-strand to look for
(beta length), give the maximum energy allowed for the backbone clash between the two
chains (max E allow), and the maximum RMSD between an exposed strand on a scaffold and
the idealized peptide (max RMSD)
3.2.3 Interface design of selected scaffolds
All design steps were carried out using the RosettaScripts framework(27). An example
RosettaScripts input file and command line to design a binder to PCSK9 are given in Sec-
tion 3.5.1 on page 70. Several different design protocols were used to obtain design models
depending on the scaffold and target protein. In general the steps are similar to those outlined
in Section 2.2.2 on page 26. The two proteins to design are moved apart, repacked, then
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docked back together to sample rigid body degrees of freedom. Once docking has been com-
pleted residues at the interface on the scaffold protein are designed while the interface residues
on the target are allowed to change rotamer but not amino acid identity. After the design
step, the backbone and side-chains at the interface are minimized on both proteins. Different
numbers of iterations are performed depending on the target and scaffold. These steps are
similar to those first used to design a protein to bind to PAK1 (28).
3.2.4 Protein expression and purification
The gene coding for RalA was obtained in the vector pGEX4T-1 and expressed as a GST
fusion protein as described by Fukai et al (8). RalA was cleaved from GST using thrombin
(Sigma) and purified to > 95% as judged by Commassie blue staining. The GDP bound to
RalA after purification was exchanged for the nonhydrolyzable GTP analog Guanosine 5-[β,γ-
imido] triphosphate (GppNHp) (Sigma) as described by Bauer et al (29). RalA-GppNHp was
then dialyzed in 1x PBS pH 7.4 to remove the excess guanine nucleotide. Genes coding for the
designed RalA binders, 1JL1aD1, 1JL1pD1, and 1SC0aD1, were ordered from Genscript and
cloned into the pET21-b expression vector. All were purified on a Ni-affinity column followed by
size exclusion chromatography (Superdex 75, Amersham). Commassie blue staining revealed
that all proteins were at 95 % purity after these steps. The designs 1JL1aD1 and 1JL1pD1
eluted from the SEC column at the expected weight of a monomer, 1SC0aD1 had the expected
molecular weight of a dimer. Although the protein 1SC0 appears as a monomer in the crystal
structure, several homologous proteins are homodimers that use the exposed β-strand targeted
for design to form part of their homodimeric interface. In retrospect it is likely that 1SC0 is
a homodimer and should not have been used in this experiment (Figure 5.1B on page 119).
HEK 293 cells expressing a FLAG-tagged PCSK9 were obtained from the Horton lab at UT
Southwestern. PCSK9 was expressed and purified as perviously described (16). Briefly, FLAG-
tagged PCSK9 was pulled down from cellular supernatant using anti-FLAG beads (Sigma).
PCSK9 was eluted from the beads using FLAG peptide. Excess FLAG peptide was removed by
running the sample over a Superdex 200 SEC column. Commassie blue staining confirmed that
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the single peak from the size exclusion column was comprised of 63 kDa and 10 kDa proteins
which correspond to the expected sizes for the PCSK9 prodomain and catalytic domain (16).
3.2.5 Yeast expression of designs
Genes coding for the EGF-A and EGF-B domains of LDLr (residues 292-373) (17), 1N3Yd1,
and 2V14d1 were ordered from GenScript and cloned into the pCTCON2b vector between the
NheI and BamHI sites. The resulting vectors were transformed into EBY100 yeast cells. The
two designs and LDLr were expressed using protocols and reagents described by Chao et al
unless otherwise noted (24). Transformed yeast were grown overnight at 30 ◦C in 1 mL of SD-
CAA media. In the morning the cells were spun down and resuspended in 200 µL of SGCAA
media; 40 µL of the resuspension was added to 960 µL of SGCAA media and grown overnight
at 20 ◦C. Protein binding and expression was checked by flow cytometry (FACSCanto, BD Bio-
sciences). Protein expression was monitored by labeling the cells with Chicken anti-c-myc IgY
(Invitrogen, catalog no. A21281) followed by Alexa Fluor 633 goat anti-chicken IgG (H+L)
(Invitrogen, catalog no. A21103). Presence of FLAG tagged PCSK9 was monitored using
anti-DYKDDDDK [Fitc] (GenScript catalog no. A01632).
3.2.6 ITC binding measurements
The affinity of RalA for Sec5 and the designed binders was measure by isothermal titration
calorimetry (MicroCal VP-ITC). The buffer used was PBS supplemented with 5 mM MgCl2.
To measure the affinity of the RalA/Sec5 interaction, RalA was placed in the sample cell at
10 µM and titrated with 150 µM Sec5 in 2 µL titrations. The affinity of the designs was
measured by titrating 600 µM Sec5 in 5 µL injections into the sample cell containing 60 µM
RalA.
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3.3 Results
3.3.1 Idealized interaction strand model
Ten residue alanine peptides were minimized to pair with the exposed β-strands on RalA
and PCSK9 as described in Methods (Section 3.2.1). The structures output from in mini-
mization protocol were chosen based on the number of backbone-backbone hydrogen bonds
formed to the target and the lowest average energy per hydrogen bond. Many of the lowest
energy peptides had similar backbone conformations (Figure 3.3). These peptides were later
truncated to contain just the residues involved in forming backbone-backbone hydrogen bonds
to the target.
3.3.2 Scaffold search protocol
The idealized stands found in the previous step were used to search for proteins with
exposed β-strands that exhibit a similar backbone conformation (Figure 3.4 red boxes). Once
an exposed strand on a scaffold protein is found (Figure 3.4 blue boxes) it is aligned to the
idealized strand. If the backbone of the scaffold and peptide are similar (RMSD < 1.5 A˚)
and the backbones of the scaffold and target do not clash, the structure is output for design
consideration (Figure 3.4 green boxes). Of the 5,200 protein chains searched against, about
50 produced suitable matches to either RalA or PCSK9. This is a similar result to that found
when scaffold proteins were screened to determine if they could form a potential β-strand
mediated homodimer (Figure 2.1).
3.3.3 Selection of interface designs
The resulting structures from the scaffold search protocol (Figure 3.4) were used as in-
put conformations for interface design. Typical interface design runs (Section 3.2.3) produced
50,000 output structures. We selected designs for expression based on presence of intermolec-
ular β-strand mediated hydrogen bonds, favorable binding energy density (∆Gbind/∆SASA ),
lack of unsatisfied polar atoms at the interface, and visual inspection (Table 3.1).
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Figure 3.3: Idealized backbone conformation of three strands pairing with target proteins.
Alanine peptides were minimized with Rosetta to bind to the exposed β-strands on A) RalA
(olive) and B) PCSK9 (green). Black dashed lines represent main chain hydrogen bonds.
We choose three designs to test for binding to RalA (Figure 3.5). Ribonuclease H1 (PDB
ID: 1JL1) (30) was designed to form a parallel (1JL1pD1; Figure 3.5B) and antiparallel
(1JL1aD1; Figure 3.5A) β-strand paring with RalA. The other design forms an antiparal-
lel intermolecular β-sheet using a scaffold protein of unknown function (PDB ID: 1SC0). This
design was named 1SC0aD1 (Figure 3.5B).
Two potential binders to PCSK9 were selected based on redesigns of human α-X β2 integrin
I domain (PDB ID: 1N3Y) (31) and KIF16B (PDB ID: 2V14) (32). The designs based on
these domains were named 1N3Yd1 and 2V14d respectively. Each design forms an antiparallel
intermolecular β-sheet with PCSK9 that includes three backbone-backbone hydrogen bonds.
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Figure 3.4: Search protocol used to find potential scaffolds to form a novel β-strand me-
diated interface with a target protein. Full details are outlined in Materials and Methods
(Section 3.2.2). Steps shown here for matching a peptide (blue) modeled to interact with
RalA (olive) to a scaffold (PDB ID: 1JL1) (pink) with an exposed strand (blue). The peptide
in RalA and exposed strand on the scaffold are aligned to generate a potential starting struc-
ture for interface design. This protocol was also used to find potential partners for PCSK9.
1N3Yd1 forms an additional side-chain to backbone hydrogen bond to PCSK9 and uses an
arginine to pack against PCSK9 residue F397 (Figure 3.6A), which has been shown to be
critical for binding to LDLr (17). The design 2V14d1 forms more hydrophobic contacts with
PCSK9 (Table 3.1) and packs against PCSK9 F297 with a proline and the main chain of an
α-helix (Figure 3.6B). Only two designs were selected in order to optimize the yeast display
expression system. There are several other scaffold proteins can be used if 1N3Yd1 and 2V14d1
fail to produce binders from a library.
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Target Design ∆SASA (A˚2) ∆Gbind/∆SASA No. buried-unsatisfied Polar interface area (%)
RalA Sec5 (native) 904 -0.028 1 54
RalA 1JL1aD1 1328 -0.023 0 49
RalA 1JL1pD1 1052 -0.027 2 51
RalA 1SC0aD1 1214 -0.018 2 63
PCSK9 LDLr (native) 975 -0.021 1 47
PCSK9 1N3Yd1 1087 -0.021 0 51
PCSK9 2V14d1 1038 -0.020 0 45
Table 3.1: Computational evaluation of heterodimer design models. Native interactions of
RalA to Sec5 and PCSK9 to LDLr are given for comparison. ∆SASA represents the change
in protein surface area upon binding, ∆Gbind/∆SASA is the energy density at the interface
(∆Gbind= EAB − EA − EB), No. buried-unsatisfied is the number of polar atoms that are
not solvent accessible and do not form hydrogen bonds to another atom in the protein, and
Polar interface area, % represents the amount of solvent-accessible surface area of polar atoms
hidden at the interface (SASApolar/SASAtotal).
3.3.4 Affinity measurements of designed binders to RalA
The binding affinity of the designs for RalA-GppNHp was measured by ITC, Sec5 was used
as a positive control. Titrating Sec5 into RalA showed an exothermic interaction (Figure 3.7A).
A fit of the curve revealed that Sec5 bound to RalA with KD = 340 nM with a molar ratio of
n = 0.55. These values are close to those reported previously; KD = 140 nM, n ≈ 1.0 (8). The
discrepancy in the molar ratio could be caused by incomplete exchange of GDP for GppNHP
in RalA. Titration of the designs into RalA produced endothermic peaks for all designs and
no discernible binding interaction (Figure 3.7B, C, D). RalA is able to bind a natural effector,
however our attempt to design a novel binder was unsuccessful.
3.3.5 Yeast display of proteins to bind PCSK9
Labeling of yeast cells with anti-c-myc antibody indicates that LDLr, 1N3Yd1, 2V14d1
can be displayed on yeast surface. This indicates that yeast surface display can be used as
a system to evolve binding between 1N3Yd1, 2V14d1 and PCSK9. The next step was to
test the designs and LDLr to determine if they bind to purified PCSK9. The binding affinity
of PCSK9 to LDLr was measured as described previously (21). PCSK9 was labeled with
anti-FLAG antibody.
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Figure 3.5: Proteins redesigned to bind to RalA (olive). The whole modeled structure of the
complex formed by both chains is shown on the left with a more detailed look at interactions
at the interface is shown on the right. The models are 1JL1aD1 (A, blue), 1JL1pD1 (B, blue)
and 1SC0aD1 (C, purple). Black dashed lines represent hydrogen bonds across the interface.
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Figure 3.6: Proteins redesigned to bind to PCSK9 (green). The whole modeled structure
of the complex formed by both chains is shown on the left with a more detailed look at
interactions at the interface is shown on the right. The models are 1N3Yd1 (A, orange),
2V14d1 (B, maroon). Black dashed lines represent hydrogen bonds across the interface.
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Figure 3.7: Isothermal calorimetric titration of RalA with the Sec5 and the designed scaffold
proteins. Top pannel shows the raw data for each injection. Bottom panel shows the molar
ratio of titrant protein to RalA vs integrated heat of addition from top pannel. A) Native
interaction between RalA-GppNHp titration with Sec5 shows binding with an affinity of 340
nM with a molar ratio of 0.55. There is no detectable binding between RalA-GppNHp and
the designed proteins B) 1JL1aD1, C) 1JL1pD1, and D) 1SC0aD1.
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3.4 Discussion
The computational workflow described here represents a general way to find potential
binders capable of forming an intermolecular β-sheet with a target protein. A peptide repre-
senting ideal β-strand pairing could be build along the exposed strand of any target protein.
The search method will then find exposed strands on scaffold proteins that are a close match
to the idealized strand. Thus far this protocol has only been applied to target proteins that
bind to a natural effector protein along the exposed β-strand. Ribonuclease H (PDB ID: 1JL1)
would be an interesting target protein because it has a long exposed β-strand and no know
natural effectors that bind via this strand.
The computational results are promising. The designs chosen for expression all made at
least three main chain hydrogen bonds to their target. The interface design method produced
interfaces with similar energies and composition to natural binders to the target proteins 3.1.
Design of four other scaffolds also yielded designs with similar interface energy. However, the
experimental results have been disappointing. None of the three proteins designed to bind
RalA had any measurable affinity for their target. The two designed binders to PCSK9 also
showed no discernible interaction even though yeast display is capable of detecting low affinities
(3). The computational models suggest that the backbone conformation of the scaffold should
be able to form an intermolecular β-sheet with the target protein. An alternative method of
sampling sequence space could produce proteins that are able to bind.
3.4.1 Future direction: evolving binders to PCSK9
Even though there was no detectable binding of PCSK9 to the designs, there is the potential
to use directed evolution to develop binders to PCSK9. The rate of success in computational
protein-protein interface design is about 1 in 20 (Chapter 4 and Table 4.1), which makes
it prudent to screen a large number of interface designs. Yeast surface display provides the
ability to screen large libraries of sequences (up to 109) and select clones that bind to the target
with FACS (24). The designs were expressed as yeast surface fusions to test their viability in
this system. The potential pairing between the exposed β-strand on PCSK9 and the scaffold
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should serve as an anchor for the interaction and allow the incorporation of additional sequence
diversity on the scaffold protein at the targeted interface. Yeast surface display was used to
increase the affinity of a weakly binding computational design (3; 33). Directed evolution of
proteins with exposed β-strands can enable them to interact with amyloid fibrils (34), which
suggests β-strand pairing can be obtained through directed evolution
3.4.2 Computational library generation
The first step in directed evolution is the generation of a library. Rationally designed
libraries that increase the frequency of useful variants are necessary as sequence space can
become too large as more sites are included in the library (35). Computationally designed
libraries can limit search space to amino acids that are reasonable for a protein’s conformation
and have been shown to produce the desired outcome better than random libraries or error
prone PCR (36; 37; 38). A possible approach to computational library design is to generate an
ensemble of backbone conformations in the scaffold protein followed by designing all positions
at the predicted interface with PCSK9. The residues that Rosetta prefers at each position
would then included in a library. Backbone flexibility is required to recapture conformation
changes upon mutation (39). Degeneracy in Ramachandran space for β-strands (Figure S2.6)
suggests backbone modeling will not significantly alter the ability of the β-strand to pair with
PCSK9. Since sequences would only be allowed to vary near the predicted interface and β-
strand paring would be available to orient the interface, it is unlikely off target binding will
appear. This even could be checked for by testing the ability of LDLr to bind to PCSK9 in
the presence of the designed protein. This method should provide sufficient sequence diversity
without sacrificing the stability of the scaffold proteins.
Design of a novel β-strand mediated heterodimer is remains an unsolved problem. Compu-
tational results demonstrate that it is possible to find proteins with exposed stands capable of
forming a heterodimer with at target, however design has failed to produce a sequence capable
of interacting with the target. Alternate methods such as searching for exposed strands that
match the conformation of a known interacting strand could provide additional scaffolds for
68
design. Another possibility is to test a greater repertoire of designs by using yeast display
rapidly screen designs and evolve new binders.
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3.5 Supporting Information
3.5.1 Design method for targeting PCSK9
The following is the RosettaScripts method used to design scaffold proteins to bind to
PCSK9
rosetta3/rosetta_source/bin/rosetta_scripts.<EXE>
-database <ROSETTA_DATABASE>
-s input_struct.pdb
-ignore_unrecognized_res
-parser:protocol script.xml
-nstruct 9000 -jd2:ntrials 5 -jd2:delete_old_poses
-out:pdb_gz true
-score12prime true -no_his_his_pairE -no_optH false
-docking:dock_pert 3 5
-ex1 -ex2 -use_input_sc -extrachi_cutoff 1
-linmem_ig 10
-run::min_type dfpmin_armijo_nonmonotone
-atomic_burial_cutoff 0.01 -sasa_calculator_probe_radius 1.2
-overwrite
With the following as the input to script.xml.
<ROSETTASCRIPTS >
<SCOREFXNS >
<s12_prime weights="score12prime"/>
</SCOREFXNS >
<TASKOPERATIONS >
<RestrictToInterfaceVector name=vectorTask chain1_num =1
chain2_num =2 CB_dist_cutoff =10.0 nearby_atom_cutoff =5.5
vector_angle_cutoff =65.0 vector_dist_cutoff =8.0/>
<RestrictChainToRepacking name=repack1 chain =1/>
<RestrictChainToRepacking name=repack2 chain =2/>
<RestrictToRepacking name=repackonly/>
<InitializeFromCommandline name=cmdTask/>
<IncludeCurrent name=currentTask/>
</TASKOPERATIONS >
<FILTERS >
<ScoreType name=score_filter scorefxn=score12
score_type=total_score threshold =-1/>
<Ddg name=ddg_filter scorefxn=score12 threshold =-10 jump=1
repeats =3 repack =1/>
<Sasa name=sasa_filter threshold =900 jump =1/>
<BuriedUnsatHbonds name=unsats_filter jump_number =1 cutoff =8/>
<Rmsd name=rms threshold =5.0 confidence =1/>
</FILTERS >
<MOVERS >
<PackRotamersMover name=initial_pack scorefxn=score12
task_operations=repackonly ,cmdTask ,currentTask/>
<PackRotamersMover name=design_pack scorefxn=s12_prime
task_operations=vectorTask ,repack1 ,cmdTask ,currentTask/>
<MinPackMover name=design_min_pack scorefxn=score12
task_operations=vectorTask ,repack1/>
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<Prepack name=prepack scorefxn=s12_prime jump_number =1 min_bb =0
task_operations=vectorTask ,repackonly ,cmdTask ,currentTask/>
<DockingProtocol name=dockprotocol docking_local_refine =0
docking_score_high=score12 ignore_default_docking_task =1
task_operations=vectorTask ,repack1 ,repack2 ,cmdTask ,currentTask/>
<TaskAwareMinMover name=minmover scorefxn=s12_prime chi=1 bb=1
jump=1 task_operations=cmdTask ,currentTask/>
<ParsedProtocol name=designmin mode="sequence">
Add mover_name=design_min_pack
<Add mover_name=design_pack/>
<Add mover_name=minmover/>
</ParsedProtocol >
<build_Ala_pose name=ala_pose partner1 =0 partner2 =1
interface_cutoff_distance =8.0/ >
<SaveAndRetrieveSidechains name=retrieve_sidechains allsc =0/>
<IteratedConvergence name=designiterate mover=designmin
filter=score_filter delta =2.0 cycles =1 maxcycles =10 />
<InterfaceAnalyzerMover name=fullanalyze scorefxn=score12
packstat =1 pack_input =0 jump=1 tracer =0 use_jobname =1 resfile =0
/>
<FavorNativeResidue name=favornative bonus =0.5/ >
</MOVERS >
<APPLY_TO_POSE >
</APPLY_TO_POSE >
<PROTOCOLS >
<Add mover_name=prepack/>
Add mover_name=ala_pose
Add mover_name=favornative
<Add mover_name=dockprotocol filter_name=rms/>
Add mover_name=retrieve_sidechains
<Add mover_name=designiterate filter_name=rms/>
<Add filter_name=score_filter/>
<Add filter_name=ddg_filter/>
<Add filter_name=sasa_filter/>
<Add filter_name=unsats_filter/>
<Add mover_name=fullanalyze/>
</PROTOCOLS >
</ROSETTASCRIPTS >
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Chapter 4
A comparison of successful and failed
computational protein interface designs
4.1 Introduction
Computational protein design methods have progressed rapidly in recent years but several
challenges remain. One of these is the design of new protein-protein interactions (1; 2). Other
than notable success in designing α-helical pairing and specificity (3; 4; 5), there are no general
methods for computationally designing novel interactions and successful designs are largely
outnumbered by failed ones (6).
Directed evolution of protein-protein interactions has demonstrated that it is possible to
generate high affinity binders to most target proteins (7; 8). Computational interface design
has not developed nearly as many affinity reagents as directed evolution but can provide
the ability to target specific regions of a target protein to modify function (1). Progress in
computational design has been confounded by the complex nature of protein-protein interfaces
including large numbers of polar interactions (9), importance of solvation loss upon binding
and long range electrostatics (10), and water mediated hydrogen bonds (11). It is difficult to
model these aspects in the context of a protein design simulation. It is important to correctly
model polar interaction because an important determinant of an interface’s ability to form is
the extent to which interface spanning hydrogen bonds compensate for a desolvation penalty
(12).
There have been many attempts to computationally design new protein-protein interac-
tions, however only a few designs that have been experimentally shown to have high affinity
(KD ≤ 1 µM) and adopt the computationally predicted structure. Experimental validation of
computational designs is a necessary step not only to confirm a design matches the prediction,
but to provide insight into improvements in the energy function and search methods used in
a computational protocol (1). However, cloning, expression, affinity measurements, and struc-
ture determination can make experimental verification of a design time consuming. Typical
interface design simulations can output hundreds of plausible models with similar energy mak-
ing it imperative to apply additional metrics to select which designs to carry forward to an
experimental system.
One recent study sought to improve design selection methodology by asking the compu-
tational protein docking community to determine metrics that discriminate designed proteins
that were known not to bind from natural interfaces (6). Some of the best discriminating
metrics showed that the designs had unfavorable solvation energy at the interface and poor
electrostatic complementarity between the two proteins in the complex. However, most of
the metrics failed to distinguish natural small hydrophobic interfaces from designed small
hydrophobic interfaces.
Here, we examine some of the successful and failed attempts to use Rosetta to design
protein-protein interactions and compare them to interfaces of natural proteins. In general
we find that the designs are smaller and more hydrophobic that native protein interactions.
Though most designs fail to form experimentally, the ones that do are dominated by hydropho-
bic packing interactions at the interface. All attempts to designing polar, hydrogen bond rich,
interfaces failed to bind experimentally. We then address possible causes and solutions to the
discrepancies between designed and native protein-protein interfaces.
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4.2 Methods
4.2.1 Definition of an interface residue
A residue is defined as being at a protein-protein interface if it passes either of two criteria:
(i) the distance from one of that residue’s side-chain atoms to an atom on the other chain is
short (less than 5.0 A˚); (ii) the Cβ of the residue in question is less than 9.0 A˚ from the Cβ
of a residue on the opposite chain and its Cα-Cβ vector points at the opposite chain. This
method of determining the interface is termed the interface vector definition. To calculate if
a residue passes the first criterion, all residues nearby residues on the opposite chain( Cβ to
Cβ distance within 10.0 A˚) are found. Next the distance from all side-chain atoms in that
residue to the nearby residues on the opposite chain are calculated. If any of those distances
are less than 5.0 A˚ then the residue is considered to be at the interface. Residues that do
not pass this check are then examined to determine if they meet the second criterion. Two
vectors are drawn, a
−−−−−−−−−→
Cα(A)Cβ(A) vector and another vector
−−−−−−−−−→
Cβ(A)Cβ(B) (Figure 4.1A). If the
distance from between the Cβ on the different chains is short enough ( |
−−−−−−−−−→
Cβ(A)Cβ(B)| < 9.0 A˚),
these vectors are then normalized and the dot product between them is calculated. If either
residue does not have a Cβ atom then one is built onto it using the idealized position of a Cβ
in alanine. The residue on chain B is considered to be at the interface if the angle between
−−−−−−−−−→
Cα(A)Cβ(A) and
−−−−−−−−−→
Cβ(A)Cβ(B) is less than 65
◦ (ie. ̂Cα(A)Cβ(A) • ̂Cβ(A)Cβ(B) > cos 65◦). In
Rosetta, residues at a protein protein interface are typically defined as all amino acids that
have a Cβ on one chain to Cβ on the other chain distance of less than 8.0 A˚. This is termed
the interface neighbor definition. When an interface is defined in this manner, several of the
residues considered to be at the interface are in fact pointing towards the core of the protein
and could not be designed to be at the interface (Figure 4.1B). The interface vector definition
avoids this problem by only considering residues to be at the interface if they are very close to
the other chain or point at it (Figure 4.1B).
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Figure 4.1: Method of finding residues at a protein-protein interface of chain A (purple)
and chain B (green). A) Illustration of how the vectors and distances are drawn to determine
interface residues. The highlighted arginine on chain A includes the tyrosine and leucine on
chain B in two different ways. The tyrosine is included at the interface because the distance
from an arginine side-chain atom to any atom on the tyrosine is less than the cutoff of 5.0
A˚. The arginine on chain A includes the leucine on chain B because |−−−−−−−−−→Cβ(A)Cβ(B)| < 9.0
A˚ and the angle between
−−−−−−−−−→
Cα(A)Cβ(A) and
−−−−−−−−−→
Cβ(A)Cβ(B) is less than the cutoff of 65
◦. B)
Example interface of two chains (PDB ID: 1GL4), different chains are shown in light blue
and light green. Residues defined at being at the interface on the light blue chain by either
the neighbor definition or vector definition are shown in sticks. Residues shown in orange are
those determined to be at the interface by both methods. Residues in grey are those defined
only by the neighbor definition, while residues in purple are those counted only by the vector
definition.
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4.2.2 Input structure energy minimization
Many protein X-ray crystal structures have minor clashes of atomic radii, improper orien-
tation of asparagine, glutamine, or histidine side-chains, or backbone dihedral angles outside of
acceptable ranges (13). All of these problems can adversely affect the Rosetta score function.
Thus every input X-ray crystal structure was repacked and minimized with Rosetta. This pro-
cess has three steps. First, the side-chain χ angles are minimized to optimize local contacts,
next a full rotamer packing step is done to relieve any clashes that minimization could not
solve. Finally, the side-chains, backbone and rigid body orientation is minimized to obtain
the structure used for further analysis. Most minimized output structures had an RMSD of
less than 1.5 A˚ to the native crystal structure. The designed models were also run through
this protocol to allow comparison between the designs and native structures. An example
command line for this protocol is given below:
./min_pack_min.<exe>
-database <rosetta_database>
-l start_structs.list
-pack_first false
-no_rbmin false
-min_all_jumps true
-nstruct 50
-score12prime true
-out::pdb_gz true
-ndruns 5
-run::min_type dfpmin_armijo_nonmonotone
-use_input_sc true -ex1 -ex2 -extrachi_cutoff 1
-no_his_his_pairE true
-ignore_unrecognized_res
-no_optH false
4.2.3 Interface analysis protocol
The protein-protein interfaces were analyzed using the InterfaceAnalyzerMover (14).
This protocol takes a protein-protein complex as an input structure and then creates an un-
bound structure. The interface energy, SASA, and other metrics are calculated based on the
differences between the bound and unbound structures.
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./rosetta_scripts.<exe>
-l minimized_structs.list
-parser:protocol interface_analysis.xml
-score12prime true
-ignore_unrecognized_res
-no_his_his_pairE
-out:file:score_only IA.score.sc
-no_optH false -ex1 -ex2 -use_input_sc
-run::min_type dfpmin_armijo_nonmonotone
-extrachi_cutoff 1
-linmem_ig 10
-ignore_unrecognized_res
-atomic_burial_cutoff 0.01
-sasa_calculator_probe_radius 1.2
The script passed to parser:protocol is given in Supplementary Information (Section 4.5.3
on page 109)
4.2.4 Polar burial definition
Rosetta calculates solvent accessible surface area (SASA) using the Le Grand and Merz
method (15) and keeps the SASA up to date as described by Leaver-Fay et al (16). The SASA
for a polar atom is sum of the SASA for that atom, plus the SASA for any bound hydrogens.
A polar atom is defined as buried if the total SASA for that atom is less than 0.1 A˚2. If a
buried polar atom does not have a hydrogen bonding partner, as defined as having an H-bond
energy of less than 0.0 REUs, then that atom is considered buried and unsatisfied. A hydrogen
bond is defined as buried if the SASA for the two involved polar atoms is less than 3.0 A˚2.
Based on distances observed from low B-factor waters to protein atoms ( Reference (17) and
Figure S4.1) we chose to use atomic radii from Reduce (18) and a water probe radius of 1.2 A˚
to find buried polar atoms and hydrogen bonds.
4.2.5 Determining hydrogen bond geometry
Geometric parameters describing interface spanning hydrogen bonds were found using the
robust Features reporting interface in Rosetta (O’Meara unpublished results). Hydrogen bond
geometry features were extracted from the minimized design models, X-ray crystal structures
of the native interfaces, and set of 4400 high-resolution crystal structures (Richardson Lab
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top4400 set). An example command line to extract these parameters from a list of structures
(structures.list) is:
./rosetta_scripts.<exe>
-in:file:fullatom
-l structures.list
-out:nooutput
-parser:protocol features_script.xml
The actual features that are extracted are defined in the input XML script passed to
-parser:protocol. The protocol used for the features described here is given in Supporting
Information Section 4.5.4 (page 4.5.4). Plots of the features and hydrogen bond selection was
performed using R scripts. Interface spanning hydrogen bonds were selected from the native
dimers and the design models. Intra-chain hydrogen bonds were used from the top4400 set.
Hydrogen bonds are only counted if the sequence separation of the donor and the acceptor is
greater than five residues. This removes hydrogen bonds in α-helices from the distribution.
Hydrogen bonds from the X-ray crystal structures were only chosen if the donor and acceptor
heavy atoms had a B-factor < 40.
4.3 Results
4.3.1 Set of designed interfaces
The computational models used in this analysis represent a wide array of interface design
goals (Table 4.1). The design models fall in two main categories: i) design of one protein
chain to bind to a natural target (Figure 4.2A,C,E) and ii) design of both chains involved
in an interaction to create a novel heterodimer (Figure 4.2B) or homodimer (Figure 4.2D,F).
The majority of the designs, 140, fall into the first category. These predominantly consist
of interfaces of a scaffold designed to bind some target of interest such as a small GTPase
(Figure 4.2A, Chapter 3), PAK1 (19), proteins involved in ubiquitin transfer, and influenza
hemagglutinin from Fleishman et al (Figure 4.2C) (20). Another 11 models represent the
design of both the structure and sequence of a peptide to bind Gαi1 (Figure 4.2E) (21). The
second category is comprised of 18 redesigns of natural proteins to form homodimers mediated
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by metal binding (Figure 4.2D) (22) or β-strands (Figure 4.2F) (23), and 11 models from
Karanicolas et al where both interface forming chains are designed to form a new heterodimer
(Figure 4.2B) (24).
Of the 59 designs from our laboratory 52 of them were successfully expressed in E.
coli.Seventy-three of the eighty-eight proteins designed to bind HA successfully expressed using
yeast surface display. All of the designed pairs from Karanicolas et al successfully expressed.
The interfaces used for the native dataset were taken from those chosen by Zhanhua et al.
(25). This set is comprised of high resolution X-ray crystal structures (resolution < 2.5 A˚) of
170 homodimers and 156 heterodimers. Of these, 167 homodimers and 152 heterodimers were
read by Rosetta and used in this analysis (Table S4.1).
4.3.2 Definition of a successful design
For the purpose of this study, the computational interface designs were divided into three
categories, strong success, weak success, and failure. A strong success is defined as a high
affinity interaction (KD ≤1 µM) where the X-ray crystal structure of the complex closely
matches the computational prediction. A weak success has at least a moderate affinity (KD ≤
100 µM) and either mutational or NMR chemical shift data suggesting the interface forms as
designed. A failed design does not meet the previous criteria. Table 4.1 shows a summary
of how many designs satisfy either definition of success. A complete list of structures used is
given in Table S4.2.
There are four examples that meet the criteria for a successful protein-protein interface
design. The first is the design of the structure and sequence of a peptide that binds to
Gαi1(GLhelix-4) (21). Another example is the redesign of a protein sequence to bind to HA
(HB36) (20). The other two structurally verified designs involved the redesign of natural
monomeric proteins to form symmetric homodimers via Zn+2 binding (MID1) (22) or β-strand
pairing (βdimer1) (23). We chose to use the MID1 H12E mutant throughout the rest of this
investigation because the crystal structure was a closer match to the design. A success that
is not included in Table 4.1 is the design of a novel helical tetramer by Harbury et al (3). We
decided not to include this design in the figures because the rest of the designs are dimers.
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A! B!
C! D!
E! F!
1-­‐sided	  design	   2-­‐sided	  design	  
Figure 4.2: Computational interface design models of for several different targets and design
goals. Natural target proteins are colored green while designed binders are colored orange
(A,C,E). In the case when both sides of the interface are designed the chains are colored blue
and brown (B,D,F). A) Failed design of scaffold 1JL1 to bind to RalA. B) Model of Prb/Pdar
interaction. C) HB36 designed to bind HA. D) Zinc (grey spheres) mediated homodimer
MID1. E) Model of the peptide GLhelix-4 binding to Gαi1. F) Homodimer mediated by β-
strand pairing βdimer1.
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Four designs are classified as weak successes because there is not a crystal structure of the
modeled complex. These include a high affinity binder to HA (20), a low affinity binder to
PAK1 (19), a Zn+2 mediated heterodimer (Der unpublished results) and a β-strand mediated
homodimer (βdimer2). The high affinity designed interaction between Prb and Pdar is classi-
fied as a weak success because a crystal structure of the complex is a 180◦ rotation from the
computational model (24).
Design goal No. tested Express/soluble Strong success Weak success
PAK1 binders (19) 10 6 0 1
GTPase binders 6 6 0 0
Gαi1 binding peptides (21) 11 11 1 0
Ubiquitin or UbcH7 binders 5 5 0 0
Metal mediated homodimers (22) 8 6 1 0
Metal mediated heterodimers 6 5 0 1
β-strand mediated homodimers (23) 10 10 1 1
FNIII to SH3 3 3 0 0
Flu-hemagglutinin binders (20) 88 73 1 1
Prb/Pdar (24) 11 11 0 1
Total 158 136 4 5
Table 4.1: The numbers of experimentally tested computational protein-protein interfaces
examined in this work. The number of expressed/soluble proteins represents the number of
total that could actually be expressed in the experimental system and did not aggregate.
Strong successes are high affinity interactions (KD ≤ 1 µM) where an X-ray crystal structure
matches the design model. Weak successes (KD ≤ 100 µM) have moderate to high affinity and
other experimental evidence that the interface forms as designed. Citations are given when
available.
4.3.3 Designed interfaces are small
Natural interfaces from the Zhanhua et al. set broadly sample different interface sizes
ranging from 850 A˚2 to 10,000 A˚2 (up to 7,000 A˚2 for heterodimers) (Figure 4.3). The designs
sample much smaller interfaces ranging from 850 A˚2 to 2,400 A˚2, with the majority of designs
having an interface area between 1,000 and 1,600 A˚2 (Figure 4.3 inset). The successful designs
are represented over the range of designed interface sizes and the crystal structures of the
designs show a similar ∆SASA to the design models. There has been no successful dimer
design where the interface area is over 1,600 A˚2 suggesting that better sampling and additional
effort is required to recapitulate the sizes of native complexes.
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Figure 4.3: Size of designed and natural interfaces. The change in SASA upon binding for
natives and designs is shown. Inset: Designs only on a smaller scale. Successful designs are
highlighted by colored lines (red = GLhelix-4, blue = HB36, green = MID1, orange = βdimer1).
Solid lines represent computational designs, dashed lines represent the crystal structure of the
design. The slope of the linear regression line is not significantly different from 0 (Prism
calculation) for heterodimers and homodimers while the y-intercept is -0.017 for heterodimers
and -0.016 for homodimers. The slope of the regression line fit to the design data is non-zero
with a y-intercept of -0.022 with a correlation value of r = 0.29.
Native proteins have a similar interface energy density (∆Gbind/∆SASA ) across all sizes
of interfaces (Figure 4.4A and B) while the designed interfaces tend to vary in energy density
depending on the size of the interface. (Figure 4.4C). Larger designed interfaces tend to have
a higher ∆Gbind/∆SASA than smaller ones. This observation suggests that, unlike native
complexes, current sampling and design strategies are unable to achieve similar energy across
interface sizes. It should be noted that most of the protocols used to produce the computa-
tional designs allow rigid body motion but not substantial backbone rearrangement. Crystal
structures of the successful designs maintain a similar ∆Gbind/∆SASA to the computational
model. The minimal change in ∆Gbind/∆SASA indicates that the majority of the designed
interactions were recovered experimentally. Rosetta appears to be unable to maintain a low
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energy across a complex as the size of the interface increases. This could mean that more
backbone sampling is needed to ensure favorable contacts across a large interaction area.
It is important to note that Zn+2 binding of MID1 is not accounted for by the Rosetta
Energy function, thus binding energy calculations will be higher than reasonable for the metal
mediated designs. If it is assumed that Zn+2 binding is approximately the same energy as
a hydrogen bond, then adding in eight hydrogen bonds with an energy of -1.3 REUs, the
∆Gbind/∆SASA for MID1 (Figure 4.4 green points) would be -0.023.
4.3.4 Successful designs have few polar interactions
Most Rosetta designed interfaces have less contribution from polar interactions at the
interface than natural dimers. This was also noticed previously when comparing the proteins
designed to bind HA to another set of heterodimers (6). The successful designs also tend to have
fewer polar interactions at the interface than natives or the other designs. The amount of SASA
that polar atoms contribute to an interface normalized by the total ∆SASAof the interface
shows that the designs more closely resemble homodimers (Figure 4.5B) than heterodimers
(Figure 4.5A). The successful designs have a low fraction of buried polar area even when
compared to the other designed interfaces. For all of the successes, polar atoms contribute
less than 40% of the total interface area (Figure 4.5). The polar atom contribution to the
interface of the weak successes is also below 40% for all cases. The successful design that has
the largest fraction of polar interface area, βdimer1, has six main-chain hydrogen bonds which
account for a larger amount of buried polar area. The remainder of the βdimer1 interface is
predominantly hydrophobic.
The design of polar residues at an interface could result in the burial of a polar atom
without a hydrogen bonding partner. Native interfaces tend to have no more than two buried
polar atoms per 1,000 A˚2 of interface (Figure 4.6A). While the designs have a similar profile to
natives, three of the strong successes have no buried unsatisfied polars at the interface. HB36
has two buried unsatisfied hydrogen bonds at its interface in the X-ray crystal structure. One
of these could be removed with a rotamer substitution. The other is located on the side chain
of W57, a critical buried residue in the center of the interface.
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Figure 4.4: Interface energy density (∆Gbind/∆SASA ) designed and natural interfaces.
The change in SASA upon binding versus ∆Gbind/∆SASA is shown for heterodimers (A),
homodimers (B) and designs(C). Successful designs are highlighted by colored points (red
= GLhelix-4, blue = HB36, green = MID1, orange = βdimer1). Solid points represent the
computational model, ×’s represent the crystal structure of the design. Least-squares lines
were fit to each set of interfaces. The correlation coefficient for designs is R = 0.33.
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One of the most striking differences between designed and native complexes the amount of
energy at the interface contributed by buried side-chain to side-chain or side-chain to backbone
hydrogen bonds. The largest fraction of designs have near zero binding energy contributed by
buried hydrogen bonds (Figure 4.6B). The successful designs all have minimal buried hydrogen
bonds at the interface. MID1 and βdimer1 have none and the design models of GLhelix-4and
HB36 each have one buried hydrogen bond across the interface. The buried hydrogen bond
in GLhelix-4was not observed in the crystal structure. One new buried hydrogen bond was
introduced to HB36 during affinity maturation of the computational design.
Examples of several designed Interfaces with buried polars are shown in Figure 4.7. These
designs, and others like them, can be thought of as tests to see if it is possible to design
hydrogen bonding at interfaces similar to that observed in native proteins (26). Each of these
interfaces have a high value for buried EH−bond/∆G compared to the majority of the designs.
Two of the designs (Figure 4.7B, C) have similar contribution from buried hydrogen bonds as
native proteins but still do not interact.
This evidence suggests that design of polar interactions at a protein-protein interface is
generally unsuccessful. Buried hydrogen bonds are either not present, or recovered, in most
of the successful designs. Directed evolution, and not computational design, was responsible
for one hydrogen bond that increased the affinity of the initial computational design of HB36.
Successful designs have few buried and unsatisfied polar atoms compared to the unsuccessful
designs (Figure 4.6A) indicating that if a polar atom is placed at an interface it needs a hy-
drogen bonding partner for an interaction to happen experimentally. However, these hydrogen
bonding interactions have proven difficult to design. The difference in hydrogen bond energy
between the design model of HB36 and the crystal structure is due to the gain of a interface
spanning hydrogen bond during directed evolution that was not present in the design model.
An interface spanning hydrogen bond in GLhelix-4was not present in the crystal structure. The
designed helical bundle RH4 is also an example a successful design that relies predominantly
on hydrophobic interactions at the interface. The polar ∆SASA fraction for RH4 is 0.23, well
below that of the other successful designs observed here. It also has no buried unsatisfied polar
atoms and no buried hydrogen bonds.
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4.3.5 Rosetta designs suboptimal hydrogen bonds
The previous observations led us to investigate the interface spanning hydrogen bonds
in the models and native proteins. One feature of Rosetta designed hydrogen bonds that
stands out as being different from native proteins is the length of a hydrogen bond from a
hydroxyl donor. The distance from a donor hydroxyl hydrogen to an acceptor is centered
around 1.75 A˚ in monomers and across chains in high resolution X-ray crystal structures
(Figure 4.8A). The interfaces designed by Rosetta have a narrower distribution centered at
1.9 A˚. Rosetta’s preference for longer hydrogen bonds could result in designs that cannot form
sufficient hydrogen bonds across an interface in order to overcome the solvation penalty of
burying a polar atom.
Another aspect of Rosetta designed hydrogen bonds that is different from native hydro-
gen bonds is a different distribution about the dihedral angle given by rotation around the
acceptor-acceptor base bond (the χ angle (27)) for sp2 acceptor atoms. A diagram illustrating
the method used to generate the Lambert azimuthal equal-area projection plots is show in
Figure S4.2. In high-resolution X-ray crystal structures there is a clear orientation prefer-
ence for donor hydrogens around side-chain sp2 hybridized acceptor atoms at χ = 180◦ with
a smaller preference for χ = 0◦ (Figure 4.8B). Intra-chain (Figure 4.8B left) and interchain
(Figure 4.8B right) show similar distributions at χ = 1800◦ but interfaces have fewer donors
located around χ = 0◦. The Rosetta designed models (white points in Figure 4.8B) do not
show a strong preference for χ. Many of designed hydrogen bonds are located around χ = 90◦
and χ = 270◦ which are outside of the plane containing the lone pair electrons around a sp2
acceptor. The location of donor hydrogens around protein backbone carbonyl oxygens also
shows a preference for χ that is not recapitulated in the designed interfaces (Figure S4.3).
The differences between the intra-chain and interchain distributions are due to intra-chain
hydrogen bonds in top4400 being dominated by β-sheets. Hydrogen bonds in the interfaces
are a mix of backbone-backbone and backbone-sidechain interactions. The current Rosetta
hydrogen bond model does not contain a parameter that accounts for the preference about the
χ angle.
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Figure 4.5: Polar content of designed and natural interfaces. The polar fraction of interface
area is shown for designs versus heterodimers (A) and homodimers (B). Successful designs are
highlighted by colored lines (red = GLhelix-4, blue = HB36, green = MID1, orange = βdimer1).
Solid lines represent the computational model. Dashed lines represent the crystal structure of
the design.
4.3.6 Other observations
There are two other interesting differences between native and designed interactions. The
loss of solvation energy upon binding, after subtracting the energy of newly formed hydrogen
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Figure 4.6: Buried polars and buried hydrogen bonds at interfaces. A) The number of
buried polar atoms without a hydrogen bonding partner per 1,000 A˚2 of interface area. B)
The total energy of a buried, side-chain involved hydrogen bond at the interface as a fraction
of total binding energy (∆Gbind). Successful designs are highlighted by solid colored lines (red
= GLhelix-4, blue = HB36, green = MID1, orange = βdimer1). Dashed lines representing the
crystal structure of the design are shown when there is a difference between the computational
design and the crystal structure. The difference for HB36 in (B) is due to the addition of a
hydrogen bond during directed evolution. The loss of hydrogen bond energy for GLhelix-4is
due to the interface in the crystal structure not forming a designed, buried, hydrogen bond.
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A! B! C!
Figure 4.7: Examples of designed interfaces with buried side chain hydrogen bonds. All of
these interfaces failed to bind. Interface spanning hydrogen bonds are shown in black dashed
lines. A) FNIII (brown) designed to bind to βpix SH2 domain (grey), EH−bond/∆G = 0.262.
B) Failed design of c-Raf (aqua) to bind Rac1 (olive), buried side-chain EH−bond/∆G = 0.145.
C) Failed design of an α-helix (magenta) to bind to an ankyrin repeat protein (green), buried
side-chain EH−bond/∆G = 0.115.
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native interface!
designed interface!
native monomers!
native monomers! native interfaces!
A!
B!
Figure 4.8: Examples of Rosetta incorrectly modeling natural hydrogen bond geometry.
Hydrogen bonds from native monomers are intra-chain hydrogen bonds in the top4400 set
of structures. Native and designed hydrogen bonds are interchain hydrogen bonds at the
interfaces discussed here. Hydrogen bonds are only counted if the sequence separation of the
donor and the acceptor is greater than 5 residues. A) Kernel density (log scale) of the distance
from the hydrogen on a hydroxyl oxygen to the atom accepting the hydrogen bond. Numbers
in upper right represent the number of hydrogen bonds in the plot. B) Lambert azimuthal
equal-area projection of the location of a hydrogen donating a hydrogen bond to a side-chain
sp2 acceptor atom. Locations of the hydrogen for native monomer and native interfaces is
shown as a density. Positions of the hydrogens in designed interfaces are shown as white dots
in both density plots. The number of hydrogen bonds used in the density is shown in the
upper right.
95
is over-penalizing design of polar atoms at the interface. However, designs with many buried
polar atoms tend not to form experimentally (Figure 4.5).
4.4 Discussion
These results indicate that although it is possible to computationally design a novel protein-
protein interactions there are many more designs that fail to form the predicted complex. In
general, the designed interactions tend to be more hydrophobic and smaller than most natural
protein-protein interfaces. The successful designed interactions have even fewer polar atoms
at their interfaces than most of the designs and have little to no buried hydrogen bonds or
unsatisfied polar atoms. It was not possible to completely discriminate successful designs,
failed designs, and native interactions using the metrics described here. Previous attempts
to discriminate binding from non-binding interface designs based on polarity succeeded in
separating designed interfaces from natural heterodimers but failed to identify a design that
was experimentally found to bind (6). The lack of large interface designs could be explained
by lack of suitable protein scaffolds to form a large contact area. It has been observed that
the number of candidate scaffolds decreases rapidly as more design restraints are applied (23).
This work highlights the difficulty of designing polar interactions at protein-protein inter-
faces. There have been several examples of the successful design of new hydrogen bonds at
a natural interface (28; 29; 30), however, the redesigns have lower affinity than the wild type
interaction. New hydrogen bonds can increase the affinity of a natural interaction in some
cases (31), typically by designing a interface spanning salt bridge (32). However, there are
no buried salt bridges in the successful designs outlined here. Another strategy for increasing
affinity involves replacing a polar residue with a non-polar one, or a small hydrophobic residue
with a larger one (33). None of the examples of successful novel interface design derive a
large portion of their interface from polar interactions. Nature is able to sample and make
interfaces that computational methods have yet to realize; ones with substantial polar area
and hydrogen bond interactions (Figure 4.5A and 4.6B). Computational methods seem adept
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at designing good hydrophobic packing interactions (34) but are unable to successfully model
favorable polar interactions.
When Rosetta designs hydrogen bonds at an interface there are clear differences between
the modeled hydrogen bond and those found in X-ray structures (Figure 4.8). Of the four
designs that succeeded only one had a buried hydrogen bond that was recovered in the crystal
structure. Mistakes in the hydrogen bond model could explain why no designs with a large
amount of polar interface area have formed experimentally. If the designed interactions are
tailored to a suboptimal hydrogen bond geometry then the hydrogen bonds formed between
the chains may not be sufficiently strong to overcome a desolvation penalty. Current efforts
are underway in our laboratory to modify the hydrogen bond parameters to more accurately
recapitulate the hydrogen bonds observed in native crystal structures.
There are many more examples of successful computational redesign of natural protein-
protein interactions for increased affinity (31; 33; 35; 36; 37; 32) or altered specificity (38; 28;
29; 39; 30) than of the design of a new protein interface. Energy and search functions are able
to optimize the local interactions required for binding in the context of a known partner. The
design of a novel interface requires searching for alignments of two proteins and the addition
of new residue interactions without a native like context to help direct the simulation (2). A
search strategy that is able to orient two protein scaffolds into an arrangement similar to a
native conformation could turn the difficult problem of novel interface design into the more
tractable one of redesign of native interactions.
The successful protein-protein interaction designs outlined here show that it is now pos-
sible to design interactions using a variety of strategies as long as the interaction is small
and hydrophobic. In addition, all of the successfully designed interactions are dominated by
residues in α-helices or β-strands (Figure 4.2C-F). Three important challenges in computa-
tional protein-protein interface design remain; 1) The design of an interaction where over 40%
of the atoms at the interface are polar and several buried hydrogen bonds are made, 2) The
design of an interface larger than 1,600 A˚, 3) The design of a loop based interaction. The
absence of a successful loop mediated design is surprising given the prevalence of loops in
interfaces from phage display (7) and the development of methods to accurately design and
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model loops (40; 41). To achieve these goals it is likely that there will need to be improvements
in conformational search methods and in energy functions for protein design.
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4.5 Supporting Information
4.5.1 Figures
The distance from a low B-factor water (B < 30) to protein atoms within 4.5 A˚ was found
for 500 of high resolution structures. The protein atoms near water were then sorted by atom
type; carbon, nitrogen and oxygen. The number of atoms at a binned distance from water
were then normalized by the volume of a sphere drawn around a water. This calculation was
performed as follows:
Normalized Counts atom type =
counts atom type
4
3pir
3
Where r represents the distance of an atom from water and ’counts’ is the number of atoms at
that distance. The overall fraction was calculated by setting the largest number of normalized
counts (in this case for carbon) to 1.0 and scaling oxygen and nitrogen appropriately. The
result of this calculation is shown in Figure S4.1. The mean distances seen for oxygen and
nitrogen closely match previous observations (17).
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Figure S4.1: Histogram of the distance from low B-factor waters (B < 30.0) to oxygen,
nitrogen, and carbon in a protein. Counts were normalized by the sphere volume then the
maximum value for these counts was set to 1.0.
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Figure S4.2: Diagram of how a Lambert azimuthal equal-area projection is performed for
a hydrogen bond donated to an sp2 acceptor oxygen on a protein side chain. A vector is the
donor hydrogen to the acceptor oxygen. The intersection point of this vector on a unit sphere
around the acceptor oxygen is plotted onto a two-dimensional plane. The χ angle is defined as
the torsion angle defined by R, the carbonyl carbon, the acceptor oxygen and the hydrogen.
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native monomers! native interfaces!
Figure S4.3: Location of polar hydrogens donating hydrogen bond to the protein backbone
carbonyl oxygen shown as a Lambert azimuthal equal-area projection. Locations of the hydro-
gen for native monomer and native interfaces is shown as a density. Positions of the hydrogens
in designed interfaces are shown as white dots in both density plots. The number of points
used in the density is shown in the upper right. Hydrogen bonds are only counted if the
sequence separation of the donor and the acceptor is greater than 5 residues.
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Figure S4.4: Change in solvation energy offset by hydrogen bonding upon binding. The
change in solvation energy (∆Esol) plus hydrogen bond energy (∆EH−bond) per interface
residue for designed and native interfaces.
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4.5.2 Protein structures and models used
Table S4.1: PDB IDs of native heterodimers and homodimers used in this analysis. All of
the structures listed below can be read and minimized by Rosetta. Chains were selected based
on those described by Zhanhua et al. (25).
Heterodimer (Chains) Homodimer (Chains)
1ACB (E,I) 1A4I (A,B)
1AVA (A,C) 1A4U (A,B)
1AVW (A,B) 1AA7 (A,B)
1AXI (B,A) 1AD1 (A,B)
1AY7 (A,B) 1ADE (A,B)
1B27 (A,D) 1AFW (A,B)
1BLX (A,B) 1ALK (A,B)
1BND (A,B) 1AOR (A,B)
1BPL (B,A) 1AQ6 (A,B)
1BRB (E,I) 1AUO (A,B)
1BRL (A,B) 1BBH (A,B)
1BVN (P,T) 1BD0 (A,B)
1C1Y (A,B) 1BH5 (A,B)
1CGI (E,I) 1BJW (A,B)
1CSE (E,I) 1BMD (A,B)
1CT4 (E,I) 1BXG (A,B)
1CXZ (A,B) 1C6X (A,B)
1D4V (B,A) 1CBK (A,B)
1D4X (A,G) 1CDC (A,B)
1D6R (A,I) 1CHM (A,B)
1DFJ (E,I) 1CNZ (A,B)
1DHK (A,B) 1COZ (A,B)
1DS6 (A,B) 1CQS (A,B)
1DTD (A,B) 1D1G (A,B)
1DZB (A,X) 1DOR (A,B)
1E44 (B,A) 1DPG (A,B)
1E96 (B,A) 1DQP (A,B)
1EAI (A,C) 1DQT (A,B)
1EAY (A,C) 1DVJ (A,B)
1EFV (A,B) 1EAJ (A,B)
1EM8 (A,B) 1EBL (A,B)
1EUC (B,A) 1EHI (A,B)
1EUV (A,B) 1EKP (A,B)
1F2T (A,B) 1EN5 (A,B)
1F34 (A,B) 1EN7 (A,B)
1F5Q (A,B) 1EOG (A,B)
1F5R (A,I) 1EV7 (A,B)
1F60 (A,B) 1EWZ (A,C)
1FCD (A,C) 1EXQ (A,B)
1FFG (B,A) 1EYV (A,B)
1FIN (A,B) 1EZ2 (A,B)
1FR2 (B,A) 1F13 (A,B)
1FT1 (B,A) 1F17 (A,B)
1FYH (A,B) 1F4Q (A,B)
1G4U (S,R) 1F6D (A,B)
Continued on next page...
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Table S4.1 – continued from previous page
Heterodimer (Chains) Homodimer (Chains)
1G4Y (R,B) 1F89 (A,B)
1GL4 (A,B) 1FC5 (A,B)
1GPW (A,B) 1FJH (A,B)
1GUA (A,B) 1FL1 (A,B)
1H1S (A,B) 1FP3 (A,B)
1H2A (L,S) 1FUX (A,B)
1H2S (A,B) 1FWL (A,B)
1H31 (A,B) 1FYD (A,B)
1HE1 (C,A) 1G0S (A,B)
1HL6 (A,B) 1G1A (A,B)
1HX1 (A,B) 1G1M (A,B)
1I1R (A,B) 1G64 (A,B)
1IAR (B,A) 1G8T (A,B)
1IBR (B,A) 1GD7 (A,B)
1ITB (B,A) 1GGQ (A,B)
1J7D (B,A) 1H8X (A,B)
1JIW (P,I) 1HDY (A,B)
1JKG (B,A) 1HJ3 (A,B)
1JLT (B,A) 1HJR (A,C)
1JQL (A,B) 1HQO (A,B)
1JTD (A,B) 1HSJ (A,B)
1JTP (A,L) 1HSS (A,B)
1JTT (A,L) 1I0R (A,B)
1JW9 (B,D) 1I2W (A,B)
1K9O (E,I) 1I4S (A,B)
1KA9 (F,H) 1I8T (A,B)
1KI1 (B,A) 1IPI (A,B)
1KSH (A,B) 1IRI (A,B)
1KTZ (B,A) 1J30 (A,B)
1KU6 (A,B) 1JD0 (A,B)
1KXP (D,A) 1JMV (A,B)
1KXV (A,C) 1JOG (A,B)
1L4Z (A,B) 1JP3 (A,B)
1LFD (B,A) 1JR8 (A,B)
1LUJ (A,B) 1JV3 (A,B)
1LW6 (E,I) 1JYS (A,B)
1M4U (A,L) 1K3S (A,B)
1M9E (A,D) 1K6Z (A,B)
1MA9 (A,B) 1K75 (A,B)
1MEE (A,I) 1KGN (A,B)
1MG9 (B,A) 1KIY (A,B)
1N0L (A,B) 1KSO (A,B)
1NF3 (A,C) 1L5X (A,B)
1NLV (A,G) 1LBQ (A,B)
1NPE (A,B) 1LHP (A,B)
1NQI (B,A) 1LHZ (A,B)
1NRJ (B,A) 1LNW (A,B)
1NW9 (B,A) 1LQ9 (A,B)
1O6S (A,B) 1M0W (A,B)
1OHZ (A,B) 1M3E (A,B)
1OKK (D,A) 1M4I (A,B)
1ONQ (A,B) 1M6P (A,B)
Continued on next page...
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Heterodimer (Chains) Homodimer (Chains)
1OO0 (A,B) 1M7H (A,B)
1OP9 (B,A) 1M98 (A,B)
1OPH (B,A) 1M9K (A,B)
1OR0 (B,A) 1MI3 (A,B)
1OXB (A,B) 1MJH (A,B)
1P2J (A,I) 1MKB (A,B)
1P2M (A,B) 1MNA (A,B)
1P5V (A,B) 1N1B (A,B)
1PDK (A,B) 1N2A (A,B)
1PPF (E,I) 1N2O (A,B)
1PQZ (A,B) 1N80 (A,B)
1PVH (A,B) 1NA8 (A,B)
1Q40 (B,A) 1NFZ (A,B)
1QAV (B,A) 1NU6 (A,B)
1R0R (E,I) 1NW1 (A,B)
1R8S (E,A) 1NWW (A,B)
1RE0 (B,A) 1NY5 (A,B)
1RJ9 (A,B) 1O4U (A,B)
1RKE (A,B) 1OAC (A,B)
1S0W (A,C) 1ON2 (A,B)
1S1Q (A,B) 1OR4 (A,B)
1SCJ (A,B) 1ORO (A,B)
1SGD (E,I) 1OTV (A,B)
1SHW (B,A) 1OX8 (A,B)
1SLU (B,A) 1P3W (A,B)
1SMP (A,I) 1P43 (A,B)
1SPB (S,P) 1P6O (A,B)
1STF (E,I) 1PE0 (A,B)
1SVX (B,A) 1PJQ (A,B)
1TA3 (B,A) 1PN0 (A,C)
1TE1 (B,A) 1PN2 (A,B)
1TMQ (A,B) 1PP2 (R,L)
1TX4 (A,B) 1PT5 (A,B)
1UBK (L,S) 1Q8R (A,B)
1UGH (E,I) 1QFH (A,B)
1UJZ (B,A) 1QHI (A,B)
1US7 (B,A) 1QMJ (A,B)
1USU (A,B) 1QR2 (A,B)
1UUZ (D,A) 1QXR (A,B)
1UZX (A,B) 1QYA (A,B)
1V74 (A,B) 1R5P (A,B)
1VG0 (A,B) 1R7A (A,B)
1WQ1 (G,R) 1R8J (A,B)
1YCS (B,A) 1R9C (A,B)
1YVN (A,G) 1REG (X,Y)
2HBE (B,A) 1RN5 (A,B)
2KIN (A,B) 1RQL (A,B)
2NGR (B,A) 1RVE (A,B)
2SIC (E,I) 1RYA (A,B)
2SNI (E,I) 1S2Q (A,B)
2TEC (E,I) 1S44 (A,B)
3FAP (A,B) 1SCF (A,B)
Continued on next page...
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Heterodimer (Chains) Homodimer (Chains)
3YGS (P,C) 1SMT (A,B)
4SGB (E,I) 1SO2 (A,B)
1SOX (A,B)
1TLU (A,B)
1TRK (A,B)
1UC8 (A,B)
1V26 (A,B)
2DAB (A,B)
2GSA (A,B)
2HHM (A,B)
2NAC (A,B)
2SQC (A,B)
3LYN (A,B)
3SDH (A,B)
7AAT (A,B)
8PRK (A,B)
9WGA (A,B)
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Table S4.2: List of computational design models used here and the experimental results for
each one. All design models from our laboratory are listed here along with the successful
designs from other labs. HA design models are available from Fleishman et al (20), Pdar/Prb
models were obtained from Karanicolas et al (24). If the designed complex was crystalized a
PDB ID is listed.
Project Model Experimental result Success definition PDB
β-strand homodimer 1cc8 3742 oligomer failure
1cc8 0966 oligomer failure
1cc8 1894 oligomer failure
1cc8 4097 oligomer failure
1cc8 LeuZipper monomer failure
1cc8 4579 monomer failure
βdimer1 dimer KD = 1 µM strong 3zy7
βdimer2 dimer low expression weak
βdimer3 monomer failure
βdimer4 monomer failure
RalA binder design 1JL1 anti des1 no binding failure
1JL1 parl des1 no binding failure
1sc0 des1 dimer failure
Rac1 binder design 1c1y tf no binding failure
1c1y v no binding failure
11y wy no binding failure
Ubiquitin binder design 1JJV.ubq.11 0005 binds 30 µM / nonspecific failure
1Y8C.ubq.123 0002 KD > 50 µM failure
2ODV.ubq.9 0003 KD > 50 µM failure
Zn+2-mediated heterodimer 2d4x 0028 binds with Zn+2 20 uM weak
2d4x 0320 40 uM failure
2fz4 design KD > 100 µM failure
2onu design aggregates failure
Zn+2-mediated homodimer 1g2r 334 oligomer failure
1rz4 436 no expression failure
1yzm 329 binds with Zn+2 KD = 30 nM strong 3v1c 3v1e
2il5 335 oligomer failure
1he9 180 oligomer failure
2a90 308 monomer/dimer - poor solubility failure
2d4x 161 always monomer failure
2qov 414 monomer w/o zinc, tet with zinc failure
UbcH7 and Ankyrin designs ubch7 10266 no binding failure
helical peptide no binding failure
Ubc12 Zn Ankyrin designs 0032 I141A aggregates with zinc failure
0097 D108A D99G aggregates with zinc failure
PAK1 binder design 1i2t 233 no binding failure
spider roll binds KD = 100 µM weak
1i2t 1212 KD = 330 µM failure
1i2t 3533 not soluble failure
s032 not soluble failure
s037 KD = 160 µM failure
mbp 17 no binding failure
mbp 42 no binding failure
1mn8 17567 not soluble failure
1mn8 4957 not soluble failure
Continued on next page...
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Table S4.2 – continued from previous page
Project Model Experimental result Success definition PDB
β-pix anchor design bpix1 100 uM failure
bpix2 155 uM failure
bpix3 148 uM failure
G-tail C-term helix gtail1 non-specific binding failure
gtail2 non-specific binding failure
gtail3 non-specific binding failure
gtail4 non-specific binding failure
GoLoco extension 1255 no binding failure
1680 no binding failure
4091 no binding failure
aa 0273 no binding failure
aa 0951 binds KD = 800 nM strong 2xns
aa 0971 no binding failure
aa 0976 no binding failure
Pdar/Prb Design 11 KD < 10 nM wrong orrientation weak 3q9n
HA binder HB36 Evolved binding toKD = 4 nM strong 3r2x
HB80 Evolved binding toKD = 3 nM weak
Helical bundle tetramer as designed strong 1rh4
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4.5.3 Analysis protocol
The following XML script was used as input for interface analysis:
<ROSETTASCRIPTS >
<SCOREFXNS >
<s12_prime weights="score12prime"/>
</SCOREFXNS >
<TASKOPERATIONS >
<RestrictToInterfaceVector name=vectorTask chain1_num =1 chain2_num =2
CB_dist_cutoff =10.0 nearby_atom_cutoff =5.5 vector_angle_cutoff =65.0
vector_dist_cutoff =8.0/ >
<InitializeFromCommandline name=cmdTask/>
<IncludeCurrent name=currentTask/>
</TASKOPERATIONS >
<FILTERS >
</FILTERS >
<MOVERS >
<InterfaceAnalyzerMover name=fullanalyze scorefxn=s12_prime packstat =1
pack_input =0 pack_separated =1 jump=1 tracer =0 use_jobname =1 resfile =0
task_operations=cmdTask ,currentTask ,vectorTask/>
</MOVERS >
<APPLY_TO_POSE >
</APPLY_TO_POSE >
<PROTOCOLS >
<Add mover_name=fullanalyze/>
</PROTOCOLS >
</ROSETTASCRIPTS >
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4.5.4 Hydrogen bond features
The following XML script was used as input to extract hydrogen bond geometry for the
input proteins.
<ROSETTASCRIPTS >
<SCOREFXNS >
<s weights=score12prime/>
</SCOREFXNS >
<MOVERS >
<ReportToDB name=features_reporter db="features_hbonds.db3"
sample_source="Interfaces">
<feature name=ResidueFeatures/>
<feature name=ResidueSecondaryStructureFeatures/>
<feature name=PdbDataFeatures />
<feature name=HBondFeatures scorefxn=s />
<feature name=HBondParameterFeatures scorefxn=s/>
</ReportToDB >
</MOVERS >
<PROTOCOLS >
<Add mover_name=features_reporter/>
</PROTOCOLS >
</ROSETTASCRIPTS >
This will result in the output of a SQL database named features hbonds.db3.
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Chapter 5
Conclusion
This dissertation illustrates progress in the computational design of protein-protein in-
teractions and presents a new way of overcoming some of the challenges in interface design.
β-strand pairing at an interface can ensure orientation specificity and satisfy hydrogen bond-
ing potential. The accurate design of a symmetric homodimer is a result of this approach
(Chapter 2). It is also possible to find proteins with exposed strands that are complementary
to two target proteins, RalA and PCSK9 (Chapter 3). An analysis of successes and failures in
computational interface design shows that there has been progress devising new strategies to
create novel interactions, however most designs fail to interact with their target (Chapter 4).
All of these stories point to the conclusion that it is difficult to design hydrogen bonds in-
volving side-chains at protein-protein interfaces. β-strand interactions at an interface make it
possible to minimize the need for designed hydrogen bonds. This chapter introduces additional
uses of β-strand pairing to engineer new protein-protein interactions and some of the problems
encountered using proteins with exposed strands. It concludes by addressing ways to improve
interface design methodology and goals for computational protein-protein interface design.
5.1 Additional applications of β-strand interface design
Chapter 2 establishes the first computationally designed interaction involving β-strand
pairing between two globular domains. Chapter 3 explores how this idea could be extended
to design a heterodimeric interaction. The immediate goal is to design β-strand mediated
binding partners to a small Ras superfamily GTPase and PCSK9. These designed proteins
could be used to alter RalA signaling in cells or lower blood LDL levels. Yeast display of the
designed scaffold proteins will allow rapid screening and affinity maturation of the designs for
their target. As highlighted in Figure 1.2, β-strand pairing is used to form many other natural
interfaces. All of these could be targeted using the methods presented in Chapter 3.
One possible extension is to redesign a β-strand mediated homodimer to form a het-
erodimer. βdimer1 or another strand mediated homodimer could be used as the scaffold for
design. The design method would be similar to that employed by Bolon et al to redesign
α-helix pairing to favor formation of a heterodimer over the native homodimer (1). The design
protocol will need to simultaneously optimize the energy of the desired heterodimeric complex
while disfavoring the stability of the homodimer. A fitness function that mirrors this goal
is described in the development of a MultistateDesign program in Rosetta (2). Initial at-
tempts to redesign βdimer1 to form a heterodimer resulted in aggregation of the protein. A
scaffold homodimer that is more malleable to design or a rapid way to experimentally test the
heterodimer designs is required for further progress.
An ambitious project could be the design of a novel protein that interacts with a partner
by β-strand pairing. This could be accomplished by creating an idealized partner strand
to a protein of interest using the method described in Section 3.2.1. The remainder of the
novel protein would then be built to stabilize the idealized strand fragment while presenting
additional contacts to the target protein. Charged residues should be favored for design on the
idealized strand to serve as protecting groups to prevent aggregation of the designed protein.
This de novo protein would most likely have mixed α/β secondary structure because the design
of novel all β protein has proved elusive (3).
5.2 Difficulties in β-strand interface design
One of the major impediments to designing additional β-strand mediated protein-protein
interactions is the availability of scaffold proteins with complementary exposed strands. It
is unsurprising that most proteins do not fit the desired criteria given previous observations
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that proteins with exposed β-strands are negatively designed to avoid edge strand pairing(4).
Although a search protocol found 1,100 exposed strands in a starting set of 5,500 protein
structures (see figure 2.1 on page 31), only 50 of these were finally considered to be designable
as homodimers. Of those 50, only two (PDB IDs: 1CC8 and 2A7B) were chosen as scaffolds for
further design and experimental confirmation. This illustrates the difficulty of finding proteins
with exposed β-strands suitable for design.
Many of the proteins identified as having exposed strands have specific problems, other
than those described by Richardson and Richardson (4), that make them impractical as poten-
tial design scaffolds. An exposed strand can be occluded by atoms that do not appear because
of missing density or the formation of a domain swap in the crystal structure (Figure 5.1A).
Several identified strands in the asymmetric unit of a crystal structure actually form an in-
termolecular β-sheet in a homo-oligomeric complex (Figure 5.1A). Exposed strands are also
identified at the N or C terminus of a potential scaffold. These regions can be highly flexible
(Figure 5.1C), making it unreasonable to expect the strand to maintain conformation during
design. While screening of scaffolds to find potential binding partners to RalA we identified
several exposed β-strands forming crystal contacts to other exposed strands in the crystal
lattice. This fact informed our decision to identify for and avoid while these scaffolds while
picking candidate monomers for homodimer design. Better annotation of structures in the
PDB would help alleviate many of these problems.
Proteins with exposed β-strands proved difficult to work with experimentally. Four of
six designs based on the scaffold 1CC8 formed large oligomers in solution (Table S4.2). Of
the four designs of 2A7B (βdimer1-4), two expressed poorly and could not be obtained in
quantities sufficient for additional experimental characterization. Redesigns of βdimer1 to
form a heterodimer led to the protein aggregating uncontrollably in solution. Redesigns of a
protein to form a heterodimer with a GTPase were less problematic, most likely because the
targeted interfaces were polar (Tables 3.1 and S4.2).
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A!
B!
C!
Asymmetric unit! Symmetry mate!
Crystal structure! NMR structure!
Figure 5.1: Problems frequently encountered when identifying exposed β-strands from pro-
tein crystal structures. β-strands identified as solvent exposed are shown in blue. A) A strand
appears to be exposed but the overall conformation of the extended loops in the asymmetric
unit does not seem realistic (PDB ID: 1WWC). Building in symmetry related protein molecules
reveals a strand swapped dimer that now partially occludes the exposed strand. B) An exposed
strand in the asymmetric unit of a protein (PDB ID: 1SC0) is clearly involved in forming a
β-strand mediated homodimer when the appropriate symmetry mate is modeled. C) Exposed
strands are frequently identified at the flexible N-terminus or C-terminus of a protein (PDB
ID: 1CC8). These regions can be highly flexible as observed in an NMR structure of the same
protein (PDB ID: 2GGP).
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5.3 Improvements in interface design methodology
The high failure rate of computational interface design (Table 4.1) indicates that improve-
ments are needed in both design methodology and metrics for discriminating design simulation
outputs. Successful interface design has been made possible by devising new strategies within
existing energy functions and search methods. Among these are ways to ensure proper orien-
tation of an interface using either β-strands pairing (5) or metal coordination (6; 7). Other
methods involve grafting known side-chain hot-spots onto new scaffolds (8; 9; 10; 11), trans-
ferring know binding epitopes to a different protein (12; 13; 14), or fitting a helix into a
hydrophobic groove (10; 15; 12). The need for specialized strategies to create novel interfaces
underscores the difficulty of the problem. None of the methods highlighted above could be
described as a general method for designing any interaction.
Energy functions for computational design need to be improved to make interface design a
more tractable goal. Rosetta has difficulty designing native-like hydrogen bonds (Chapter 4)
and modeling electrostatic complementation at protein interfaces (16; 10). Attempts to re-
weight the existing scoring terms in the Rosetta energy function failed to improve sequence
recovery or prediction of ∆∆Gbinding, suggesting that the energy terms for hydrogen bonding,
Lennard-Jones interactions and electrostatic interactions need to be altered to improve inter-
face design. The Rosetta community is currently parameterizing new potential functions for
hydrogen bonding and electrostatics. The use of these new potentials could allow for successful
design of polar interactions that closely resemble native heterodimers.
Alternative, more computationally expensive, simulations have been used to discriminate
and rank Rosetta designed models. A molecular dynamics protocol successfully ranked the
activities of several Rosetta designed enzymes performing a Kemp elimination reaction (17).
Rusio et al found that protein dynamics could distort the active site conformation of a com-
putationally designed retrol-aldolase and lead to lower activity than expected (18). A set
of protein-protein interface metrics including knowledge based interaction networks, molecular
mechanics force fields, and electrostatic encounter complex modeling can help determine which
interface designs that are unlikely to form a complex (16; 19). Additional computational met-
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rics or robust molecular mechanics simulations could help eliminate designs that are likely to
fail. However, given the low cost of ordering genes and use of yeast display to screen designed
interactions, time intensive discrimination methods might not be worthwhile.
The successes in de novo computational protein interaction design suggest there are a
few general guidelines that appear work across design goals. Rosetta is most successful when
designing small hydrophobic interfaces. The successes thus far involve interactions of α-helices
with other α-helices or β-strand pairing, thus the scaffold secondary structure chosen for design
should match that of the targeted interface. With the exception of β-strands pairing, buried
polar atoms are detrimental to a designed interface. Even buried polar atoms involved in
hydrogen bonds are not favorable due to Rosetta’s difficulty in designing hydrogen bonds with
native-like geometry. Finally, it is imperative to have experimental methods to rapidly evaluate
and improve a successful design. Fleishman et al used yeast display to test as many designs
in two years as our laboratory had in seven 4.1.
5.4 Future of computational interface design
As discussed in Chapter 4 there are several remaining challenges for computational de-
sign to successfully recapitulate the diversity seen in natural protein complexes. Despite these
fundamental difficulties, there are foreseeable contributions that interface design could make
to biological engineering. The rise of synthetic biology has illustrated the need for new, pre-
dictable, protein-protein interactions (20). Computational protein-protein can contribute new
tools to enable design of novel biological functions.
The predominant focus of computational protein interface design has been on creating and
modifying dimeric protein-protein interactions (21). Oligomers with three or more subunits
represent over 40% of proteins in E. coli (22). Computational interface design has, with one
notable exception (23), not been able to recapitulate the abundance of oligomeric complexes
seen in nature. Accurate design of an oligomeric scaffold could allow for for precise control
of orientation and function a pathway in cells (24). Dueber et al demonstrated that modular
protein scaffolds can be used to control metabolic flux (25). Computational interface design
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could also be applied to the creation of a large symmetric homooligomer. Rosetta’s ability
to model a user defined symmetry (26) and clear rules for the formation of symmetric com-
plexes (27; 22) should allow for the design of a multi-subunit structure similar to hemoglobin
or bacterial microcompartments (28). Most previous attempts to make β-strand mediated
assemblies have resulted in uncontrolled fibrillization (29). The ability to accurately design
β-strand pairing could make it possible to create new assemblies that are well behaved.
Engineered protein-protein interactions can be as a tool to predictably manipulate cell
functions (21). One of the challenges is creating orthogonal interactions that avoid cross
talk with natural cellular pathways (20). Several groups have used computational to create
second-site suppressor mutations that make an interaction specific for the redesigned pair
and avoid interacting with a native target (30; 31; 32; 33). An important next step is the
design a signaling hub that interacts with various partners (21). The second-site supressor
strategy would not be useful for proteins that serve as signaling hubs and share a common
interface with several downstream effectors, such as the Ras superfamily. A recently developed
MultistateDesign protocol in Rosetta is able to optimize an arbitrary fitness function for an
unlimited number of different desired and undesired interactions (2). MultistateDesign is an
ideal tool to design orthogonal protein interactions. As a proof of concept, MultistateDesign
was able to recover known mutations that ablate one interaction of but maintain two others
at a common location on a signaling hub (2). It could be applied to other known interfaces to
create a specificity switch or tune the affinity to alter a signaling output.
Protein-protein interface design could create new scaffolds for computational enzyme de-
sign. Several novel enzymes have been designed with Rosetta in recent years (34; 35; 36).
However, the activity of the computationally enzymes are well below most natural metabolic
enzymes. Alternative backbone conformations can provide a boost in activity of a compu-
tationally designed enzyme by increasing hydrophobic contacts with the substrate (37). The
active site of many natural enzymes is formed between protein domains or at the interface of an
oligomer (38; 39). A novel homodimer or other homo-oligomer could provide a better active
site for enzyme design than is currently available. Small molecules from the crystallization
solution were found at the interfaces of the computationally designed homodimers MID1 (7)
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and βdimer1 (5) (Figure 5.2. These interfaces could be re-engineered to increase affinity or
specificity for alternative small molecules. In fact, MID1 has hydrolase activity towards some
substrates (40).
Fin.
A! B!
Figure 5.2: Ligands from the crystallization solutions are present at the interfaces of two
computationally designed homodimers. A) A tartrate molecule (purple) is observed at the
interface of the Zn+2mediated homodimer MID1 (chain A purple, chain B olive) (PDB ID:
3V1C). B) Two symmetrically related isopropanol molecules (purple) are buried at the interface
of βdimer1 (chain A purple, chain B olive) (PDB ID: 3ZY7).
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Appendix A
Fluorescence polarization titrations and
fitting protocol
A.1 Titration calculations
How to calculate volumes for your titrations.
We will start with:
MTVT = MnVn
Where:
MT = titrant concentration
VT = volume of titrant to be added
Mn = concentration after n titrations
Vn = total volume after n titrations
Since we want to keep a running tally we can rewrite Mn and Vn as:
Vn = VT + Vn−1
Mn =
MF (VT + Vn−1)−Mn−1Vn−1
VT + Vn−1
Where MF is the desired final concentration of titrant. Note that MF = Mn for all intents
and purposes. Thus we can rewrite:
MTVT =
MF (VT + Vn−1)−Mn−1Vn−1
VT + Vn−1
(VT + Vn−1)
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Solving for VT :
VT =
(Mn−1 −MF )Vn−1
MF −MT
or
VTn =
(Mn−1 −MFn)Vn−1
MFn −MTn
Now that you know this, you can put together a table (one of the few times that Excel
is acceptable to use) that calculates what your titrations (Vadd) need to be assuming you
know the initial volume in your cuvette (Vi), the concentration of titrant (MT ) and the final
concentration (MFn) you want at a given n titration. Use the equation for VTn given above.
Titration # MF Vadd Vtotal
0 0 0 Vi
1 MF1 VT1 Vi + VT1
2 MF2 VT2 V1 + VT2
3 MF3 VT3 V2 + VT3
n MFn VTn Vn−1 + VTn
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A.2 Homodimer fitting protocol for Prism
The following is the code to fit to fluorescence polarization data (1) using Prism4 (Graph-
pad Software). In this case X is the concentration of unlabeled protein titrated into the cuvette
and Y is the polarization measurement.
;write concentration of labeled protein here
labled=0.0034
Ptotal=labled+X
; Atotal is labled, X is total unlabled []
deltaPol=Polmax-Polmin
; polarization change
; now stuff for monomer concentration
;which you need the quadratic formula for
a=2
b=Kd
c=-Ptotal*Kd
MonomerConc=(-b+sqrt(b*b-4*a*c))/(2*a)
;now the dimer concentration can be written as
DimerConc=(Ptotal-MonomerConc)/2
;write heterodimer conc as fraction of total protein
HeteroDimer=2*(labled / Ptotal)*(X/Ptotal)*DimerConc
fractionHet=HeteroDimer / labled
;Now fit to this equation:
Y=deltaPol*fractionHet+Polmin
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